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Abstract 
The increasing lifespan of the human population has been accompanied by a 
higher prevalence of cardiovascular diseases. It has been more than 50 years since the 
first heart valve was transplanted in a human patient and many new approaches in car-
diovascular transplantation and tissue engineering (TE) have been evolving ever since. 
However, the availability of human donor tissues is limited. Ideal, vital, durable, non-
immunogenic heart valve or cardiovascular replacements are not yet commercially avail-
able. Thus, a better understanding of developmental and regulating mechanisms of car-
diovascular tissues is essential to develop new implant materials. Moreover, cardiovas-
cular tissue transplants or tissue-engineered grafts need to be monitored before trans-
plantation. This thesis aimed to establish Raman microspectroscopy and Raman imag-
ing as marker-independent, non-destructive technique for quality assessment of cardio-
vascular transplants and tissue-engineered products. Towards this aim, the influence of 
an ice-free cryopreservation technique (IFC) on tissue integrity and immunogenicity of 
heart valves was analyzed. The extracellular matrix (ECM) structures of standard cryo-
preserved (FC) and IFC allograft leaflets were compared to native leaflets after long-
term implantation in sheep. Moreover, the mid-term immunogenic effects on IFC treated 
xenografts were assessed. Quantitative monitoring of interstitial cryoprotectant (CPA) 
concentrations was performed for quality control of cryopreserved heart valves. Further-
more, phenotype and tissue origin of human smooth muscle cells (SMCs) that are ap-
plied in cardiovascular TE, were analyzed. The ECM remodeling of SMC ring constructs 
under different culture conditions was monitored. In addition to Raman measurements, 
routine techniques such as immunocytochemistry, quantitative polymerase chain reac-
tion and histological staining were performed. The results demonstrate the superiority of 
Raman microspectroscopy and Raman imaging as marker-independent, non-destruc-
tive and sensitive method, which is also time- and cost efficient when compared to rou-
tine techniques. Raman analysis combined with multivariate data analysis tools allowed 
for the determination and characterization of structural ECM changes in FC heart valves 
and real-time quantification of residual CPAs. These techniques enabled the identifica-
tion and discrimination of single human SMCs based on their tissue origin and pheno-
type. Moreover, ECM remodeling in tissue-engineered SMC rings was non-invasively 
monitored. This work affirms the potential of Raman techniques for future applications 
in in situ quality assessment in cardiovascular research.
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Zusammenfassung 
Die steigende Lebenserwartung der Bevölkerung geht mit einer erhöhten Prä-
valenz kardiovaskulärer Erkrankungen einher. Seit der ersten Transplantation einer hu-
manen Herzklappe vor über 50 Jahren entwickelt sich der Bereich der kardiovaskulären 
Transplantationen und des Tissue Engineerings (TE) stets weiter. Allerdings besteht nur 
eine begrenzte Verfügbarkeit menschlicher Spendergewebe und bisher sind keine kom-
merziell erhältlichen künstlichen Ersatzgewebe verfügbar, die vital sowie nicht-immuno-
gen sind und eine langfristige Implantation überdauern. Für die Entwicklung neuer Ge-
webe ist ein besseres Verständnis der entwicklungsbiologischen und regulierenden Me-
chanismen erforderlich. Außerdem ist die Kontrolle der kardiovaskulären Transplantate 
und künstlich hergestellten Gewebe vor der Transplantation von großer Relevanz. Das 
Ziel der folgenden Studie war die Etablierung von Raman Mikrospektroskopie und Ra-
man-Bildgebung für die Marker-freie, nicht-destruktive Qualitätssicherung im Bereich 
der kardiovaskulären Transplantation und des kardiovaskulären TE. Zunächst wurde der 
Einfluss eines eisfreien Kryokonservierungsverfahrens (IFC) auf die Gewebeintegrität 
und Immunogenität von Herzklappen analysiert. Der strukturelle Aufbau der extrazellu-
lären Matrix (EZM) von standard-kryokonservierten (FC) und IFC Allograft Herzklappen-
segeln wurde nach Langzeitimplantation in einem Schafmodel mit native Herzklappen-
segeln verglichen. Zusätzlich wurden mittelfristige immunogene Effekte IFC-behandel-
ter Xenografts bewertet. Zur Qualitätskontrolle der kryokonservierten Herzklappen, wur-
den die Konzentrationen der verwendeten Cryoprotectiva (CPAs) im Gewebe bestimmt. 
Weiterhin wurden der Phänotyp und Gewebeursprung glatter Muskelzellen, die in ver-
schiedenen TE-Ansätzen Anwendung finden, analysiert. Die EZM Reorganisation in Ge-
weberingen aus glatten Muskelzellen wurde auf den Einfluss unterschiedlicher Kultivie-
rungsbedingungen untersucht. Ergänzend zu den Raman Messungen wurden Protein- 
und Genexpression analysiert und histologische Färbungen ausgeführt. Die Ergebnisse 
dieser Studie demonstrieren die Vorteile der Raman-Mikrospektroskopie und Raman-
Bildgebung gegenüber Routineanwendungen bezüglich Marker-unabhängigkeit, Zerstö-
rungsfreiheit und Sensitivität, als auch Zeit- und Kostenersparnis. Raman-Analysen in 
Kombination mit multivariater Datenanalyse ermöglichten die Ermittlung und Charakte-
risierung molekularer struktureller EZM-Änderungen in FC Herzklappensegeln sowie die 
Echtzeit-Quantifizierung von CPA Residuen im Gewebe. Des Weiteren konnten mit die-
sen Methoden humane glatte Muskelzellen anhand ihres Phänotyps und Gewebeur-
 VI 
sprungs identifiziert und unterschieden werden, sowie die Entstehung und Reorganisa-
tion der EZM in TE Geweberingen beobachtet werden. Diese Arbeit bestärkt das Poten-
tial der Raman Spektroskopie für zukünftige Anwendung in der in situ Qualitätssicherung 
von neuen Implantatmaterialien in der kardiovaskulären Forschung. 
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 3 
1 Introduction 
 
1.1  Cardiovascular Diseases 
 
The growth and ageing of the western population is accompanied with an in-
creased prevalence of cardiovascular and metabolic events that affect the vasculature 
as well as the human heart. Cardiovascular diseases are the leading cause of death 
worldwide 1, 2. Heart valve diseases occur predominantly as age-related valve deterio-
rations causing regurgitation or stenosis 3. However, congenital and rheumatic heart 
diseases are also still relevant. The annual rate of heart valve replacement surgeries 
worldwide is expected to increase to over 800.000 interventions by the year 2050 4. 
Furthermore, preponderance of metabolic diseases such as diabetes, obesity or hyper-
tension and other cardiovascular risk factors cause a constantly increasing incidence of 
cardiovascular diseases. 16% among the western population of 55 years and older suf-
fer from peripheral artery disease and coronary artery disease is the most common 
cause of death 5, 6. The first heart valve replacement surgery was performed more than 
50 years ago 7. Autologous and synthetic materials that replace heart valves as well as 
vessels have been applied in clinics for several decades now. However, all procedures 
bare risks or fail in long-term performance and the ideal durable heart valve or vascular 
replacement that is capable to grow and remodel within the patient has not been estab-
lished. 
1.1.1 Heart Valve Replacement 
Heart valve replacement surgeries are required if there is no option for a mini-
mally invasive treatment of a valvular disease. Fresh human allogeneic donor valves 
(homovitals) provide optimal hemodynamics and immunogenicity. However, their appli-
cation is limited by donor organ scarcity 8, 9. Therefore, mechanical or bioprosthetic tis-
sue valves are commonly applied. Bioprosthetic valves comprise of preserved and ster-
ilized xenogeneic or allogeneic donor valves or constructs from animal tissues such as 
bovine pericardium. Mechanical valves vary in material, shape and size and are the 
standard replacement for younger patients up to an age of 70 10. Mechanical valves 
circumvent immunogenic risk factors, however, to avoid blood clotting and thrombosis 
the patients need life-long medication with anticoagulants. Anticoagulation therapy limits 
the patients activity and lifestyle by the risk of severe bleeding 11 and involves complica-
tions especially in younger patients and women in the childbearing age 12, 13. Application 
1 Introduction 
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of bioprosthetic valves increased in the last years. However, their implantation is mainly 
indicated for patients older than 65, because these valves have a limited life-span within 
the patient 10. Thromboembolic events are avoided, however long-term failure of bio-
prosthetic valves appears due to valve deterioration and structural degeneration 14, 15. In 
a long-term study by Hammermeister et al. no significantly different outcome was ob-
served between patients with a mechanical and a bioprosthetic valve, however different 
complications occurred in the two groups 11. 
All of the heart valve replacements that are available on the market are avital 
implants. One approach for valve grafts is the generation of tissue-engineered viable 
heart valves. The basic paradigm of tissue engineering (TE) includes the isolation and 
culture of specific cells from the patient and the culture of these cells on a three dimen-
sional synthetic or natural scaffold to form a biomaterial. This constructed neotissue can 
then be implanted in the desired site within the patient for repair, replacement or regen-
eration purposes 16. Although, there is tremendous scientific input and efforts in the es-
tablishment of functional, durable tissue-engineered heart valves, many promising ap-
proaches are still in clinical trials 17. 
1.1.2 Heart Valve Leaflet Macro- and Microstructure 
A major issue in heart valve replacement is to sustain the complex heart valve 
leaflet extracellular matrix (ECM) structures that are essential for the physiological func-
tion of the heart valve. The semilunar leaflet consists of three structural layers determin-
ing the leaflets long-term durability and biomechanical properties 18 (Figure 1). The lay-
ered architectural pattern forms a flexible and soft leaflet in the unloaded state that, at 
the same time, stays inelastic under pressure 19. The fibrosa is located on the outflow 
side of the leaflet and mainly consists of circumferentially aligned collagen fibers that 
support the leaflet’s stiffness and strength and bear the load of blood pressure 19. The 
crimped structured collagen bundles in the fibrosa cause corrugation during systole that 
are released in diastole 20 (Figure 1 A, B). Collagen fiber architecture determines the 
biomechanical sustainability of the leaflets. Highly hydroxylated collagen I fibers in the 
heart valve are mainly stabilized and strengthened by trivalent hydroxylysyl pyridinoline 
cross-links 21. The degree of cross-links determines the resistance to enzymatic degra-
dation and the stability and load-bearing capability of the leaflet 22, 23. Changes in colla-
gen fiber architecture or remodeling of collagen fibers occur in cellular response to me-
chanical or biochemical triggers or traction forces and result in altered synthesis and 
degradation of collagens 24, 25. The inflow side, ventricularis, is dominated by a radially 
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aligned elastic fiber network that enables the elasticity of the leaflet and reconditions the 
contracted state during systole 19, 26. In between these two layers resides the spongiosa. 
This layer contains solvable ECM proteins such as glycosaminoglycans (GAGs), prote-
oglycans and few loosely arranged fibrous structures 27, 28. GAGs absorb water and form 
a gel-like structure that allows the retention of frictional stress and stabilizes the leaflets 
27, 29. The valves are outlined by valvular endothelial cells (VECs) forming a monolayer. 
Within the three layers so-called valvular interstitial cells (VICs) are located. Depending 
on environmental conditions, VICs influence ECM modulation by dynamic phenotypic 
switching from quiescent fibroblast-like cells to activated myofibroblasts or smooth mus-
cle-like cells 30, 31. Preserving the ECM structures is crucial for long-term performance of 
the cryopreserved and implanted leaflets. In contrary, it is controversially discussed 
whether the implants need to be viable or can be decellularized 17, 32-35. 
 
 
Figure 1. Schematic microstructure of the heart valve leaflet during diastole (A) and systole (B). 
The layered leaflet consists of the collagen-rich fibrosa on the outflow side and the elastin-rich ventri-
cularis on the inflow side. In between resides the spongiosa that mainly consists of proteoglycans. Modi-
fied from Schoen and Levy 20. 
 
1.1.3 Cryopreservation of Heart Valve Tissue 
Organ scarcity is a limiting factor in heart valve replacement. Cryopreservation 
and tissue banking enable long-term storage of heart valve tissues and allow for tissue 
accessibility at any time. Tissues are decontaminated and frozen down in specific cry-
omedia that contain cryoprotective agents (CPAs), such as dimethyl sulfoxide (DMSO), 
propylene glycol (PG) or ethane diol 36-38. CPAs limit the damaging effects of osmosis 
and diffusion on cells during freezing and stabilize the tissue while interstitial water is 
removed 39. There exist different methods of cryopreservation. Conventionally applied 
fibrosa
spongiosa
ventricularis
A B
inflow side
outflow side
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frozen cryopreservation (FC) is the standard procedure in clinics, but needs to follow 
defined cooling parameters to control the inevitable ice-formation 40. Alternative ap-
proaches, such as vitrification, avoid interstitial ice-formation 41, 42. 
To date, FC is the standard protocol for allograft tissue preservation and applies 
a mixture of 10% DMSO and medium 43, 44. However, those valves lack long-term sus-
tainability within the patient. After 12-15 years the implants undergo structural degrada-
tion, lack functionality and need to be removed 9, 45. In pediatrics leaflet durability is even 
shorter 46, 47 and due to the extended life expectation of the population an additional 
replacement surgery is often necessary, although there is a high risk of complications 
and failure 48. FC, which has been applied since more than three decades, showed ice-
crystal formation in heart valve tissues, causing tissue deterioration and leading to irre-
versible tissue damages, that limit the leaflet’s lifetime in vivo15, 49, 50. Due to these issues 
there does not exist a gold standard protocol for heart valve cryopreservation and there 
is a need for continuous improvement. TE approaches have not evolved in the expected 
speed either. Among the many TE attempts that have been developed in the last years, 
earlier approaches failed in clinics 51 and so far only few materials and procedures 
showed promising outcomes in preclinical studies 17. Thus, a protocol for an alternative 
cryomedium and cryopreservation technique was established that was proposed to 
avoid ice formation and destruction of the tissue 52, 53. Ice-free cryopreservation (IFC) of 
allografts applies VS83 medium that contains high amounts of CPAs, which allow the 
medium to approach a vitrification-like state instead of freezing and forming ice crystals 
54. VS83 allows for cryopreservation below the glass-transition temperature of the com-
bined CPAs (-124°C), without the formation of ice crystals. Preserving tissues in VS83 
medium supports storage at higher temperatures. Storage at -80 °C instead of storage 
in the liquid phase of nitrogen (-197 °C) is possible, making ice-free cryopreservation an 
economically beneficial procedure. Storage at -80 °C requires less equipment and en-
ergy and would therefore be easier accessible in less developed countries. Preclinical 
data and a mid-term (7 months) in vivo study in a sheep model already showed a supe-
rior outcome in IFC tissue matrix integrity and heart valve functionality when compared 
to FC leaflets 50, 55. As a last step before approving IFC treated tissues in clinical trials, 
a long-term in vivo study of 12 months needed to be performed in a juvenile sheep model 
to assess the long-term durability. The ovine model is the gold standard for preclinical 
cardiovascular studies. Mechanical and hemodynamic parameters are similar to human 
heart valves, due to the enhanced calcium metabolism the ovine model presents the 
1 Introduction 
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‘worst-case-scenario’ for calcifications and the ovine development is much faster than in 
humans. 12 months in sheep equal an implantation duration of around 18 years in hu-
man 14, 56, 57. 
Another question that needs to be addressed before implementing ice-free cryo-
preservation in a clinical trial is cytotoxicity of the CPAs in the VS83 cryomedium. The 
influence of CPAs on tissues and cells has broadly been discussed 58-60. CPA permea-
tion kinetics depend on various factors. Temperature and concentration as well as the 
origin of the treated tissue and the chemical composition of the CPA itself influence the 
cryopreservation procedure. Still, trial and error experiments have to be conducted to 
determine cytotoxicity in every cryopreservation approach 59. Highly concentrated CPAs 
as applied in VS83 medium were shown to be cytotoxic, although combination of several 
CPAs did not show an increased cytotoxic effect in comparison to individually applied 
CPAs 61. Regardless of the fact that decellularization by VS83 medium cryopreservation 
might be a beneficial side-effect, for safe clinical use of VS83 medium, its effects on the 
recipient’s or migrating remodeling cells need to be investigated. 
1.1.4 Vascular Tissue Engineering 
Hypertension, cardiovascular risk factors and atherosclerotic plaques strain the 
vasculature, cause thromboembolic occlusions and minimize their lifetime. For several 
decades blood vessels have been harvested from saphenous veins, radial arteries or 
internal mammary arteries which is the standard for both, coronary and peripheral artery 
autologous graft bypass surgeries 62. Nevertheless, autografts are not always available 
due to previous diseases or the lack of accessible vessels. Moreover, graft failure can 
occur after implantation 63, 64. The alternative for autologous grafts is the implantation of 
synthetic materials such as Dacron® or polytetrafluoroethylene 65, 66. However, those 
grafts showed infection or thrombosis, especially in the application as small diameter 
(<6 mm) grafts 67. Therefore, there is a high demand for new graft substitutes. Tissue 
engineered vascular grafts (TEVG) are designed to provide a low immune response and 
inflammation potential, an anti-thrombotic surface, long-term patency, the capability to 
remodel within the patient, and could replace damaged vessels in the future 68, 69. Cur-
rent approaches in TEVGs apply biodegradable natural or synthetic scaffold materials, 
which are mostly electrospun and either seeded with cells before transplantation or con-
structed to be cellularized in vivo 68. Moreover, there are scaffold-free approaches, which 
are based on the formation of so-called tissue rings by self-assembly of cells in specific 
agarose or polymer molds (Figure 2) 70, 71. Isolated smooth muscle cells (SMCs) or stem-
1 Introduction 
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cell derived SMCs are utilized in cardiovascular TE approaches 72, 73. Vascular SMCs 
play a crucial role in structural integrity and contractile regulation of blood vessels 74. 
SMCs appear and can be classified as contractile or synthetic phenotype. The contrac-
tile phenotype SMC has a low proliferation rate, expresses mainly contractile filaments 
and has a spindle-shaped morphology. The synthetic phenotype of SMCs has an in-
creased proliferation rate, expresses dominantly ECM proteins and has a rhomboid, fi-
broblast-like morphology 75, 76. However, there are also intermediate SMC phenotypes, 
which share features of both subtypes. Whereas manufacturing of scaffold materials for 
TEVGs can be well controlled and characterized, the characterization of SMCs and the 
detection and regulation of phenotypic switching remain a major obstacle 77. Despite the 
enormous effort to produce ‘off-the-shelf’ cardiovascular conduits and various clinical 
trials, commercially available TEVGs for clinical use do not exist to date 78-80. Moreover, 
feasibility of costs and manufacturing times as well as potential immune response of 
TEVGs remain an unanswered question 68. An important factor to understand and as-
sess remodeling processes and to accelerate the application of potential TEVG scaffolds 
in clinics is the establishment of reliable methods to characterize and monitor the scaf-
fold materials or involved cells 81, 82. 
 
 
Figure 2. Self-assembly of SMCs to SMC ring constructs. Isolated primary or stem cell-derived 
SMCs are seeded in agarose wells, cultured in medium for 14 days and form SMC rings. Modified from 
Dikina et al. 83  
agarose well
14 days
SMCs SMC ring
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1.2 Raman Spectroscopy 
Quality control and quality assurance of biomaterials and viable tissues remain 
major challenges in the field of biomedical research and TE 84, 85. There is a high demand 
for the evaluation of biomaterial degradation behavior and cell-matrix interactions as well 
as for real-time techniques to monitor these processes. Raman spectroscopy has gained 
relevance as an analytical tool, whereas its related technique near infrared spectroscopy 
has lost importance 86, 87. Raman spectroscopic methods are based on the detection of 
molecular vibrations in a sample induced by an incident light source. The acquisition of 
chemically-sensitive, highly-resolved Raman spectra allows for the identification of intra- 
and intermolecular changes and modifications. Raman spectroscopy enables fast, 
marker independent, non-destructive and potentially non-invasive data acquisition and 
is highly sensitive on a molecular level. 
1.2.1 The Principle of Raman Scattering 
The interaction of photons of an incoming light source and the molecules of a 
sample results in the induction of different energetic effects and frequency shifts. De-
pending on the wavelength of the incident light and the sample properties fluorescence 
(ultraviolet wavelength range), scattering (visible wavelength range) or light absorption 
(infrared wavelength range) occur 88. Incident photons of visible light can be scattered 
elastically or inelastically. Mostly, photons are scattered back at the same energy as the 
incident light. Only 1 out of 107 photons is changed in frequency and scatters inelastically 
89. Elastic scattering is called Rayleigh scattering and can be observed in the blue color 
of the sky, where blue sunlight is scattered stronger than red light 90, 91. In inelastic scat-
tering, also known as Raman scattering, energy is transferred between photons and 
molecules by the induction of a rotational or vibrational vector within the molecule. A 
frequency shift occurs in relation to the incident wavelength. This effect has first been 
theoretically predicted in 1923 by Smekal 92 and is called the ‘Raman effect’, named 
after the Indian physicist and Nobel prize laureate C.V. Raman, who first described the 
effect experimentally in 1928 93-95. Raman scattering can result in emitted photons of 
either higher or lower energy levels than the incident photons. Stokes scattering results 
in the loss of energy and a frequency shift to higher wavelength ranges (red-shifted). 
The molecules absorb light and are transferred to a higher virtual energy level. Photons 
of a lower energy level are emitted when the molecules relapse to the ground state. In 
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anti-Stokes scattering, a frequency shift to lower wavelength ranges (blue-shifted) is ob-
served 88 (Figure 3).  
 
 
Figure 3. Principles of photon-molecule interactions. Energy levels of molecules excited by incident 
photons. Anti-stokes and Stokes scattering are the two events of Raman scattering. Modified from 
Mishchenko et al.88 
 
1.2.2 Raman Microspectroscopy and Raman Imaging 
In most biological applications, Raman spectroscopy is combined with light and 
sometimes fluorescence microscopy 96, 97, referred to as Raman microspectroscopy, and 
especially allows the targeting of small structures. Both Raman scattering effects are 
used in Raman devices. Stokes Raman scattering is applied in spontaneous Raman 
microspectroscopy (Figure 4). The sample is excited through the microscopic objective 
with a laser, after focusing on the region of interest over the camera of the microscope. 
Molecular vibrations due to photon-molecule interactions result in a loss of energy of the 
emitted photons. The resulting frequency shift is specific for every molecular bond. A 
notch filter splits frequency-shifted Raman scattering from backscattered light of the 
same wavenumber as the incident light or higher. The grating of the charge-coupled 
device (CCD) camera of the spectrograph converts the photons into a Raman spectrum 
that is comparable to a biochemical fingerprint of the sample. The Raman spectrum is 
defined by the frequency shift in wavenumber [cm-1], so-called Raman shift and the 
count of scattered photons (intensity). Instead of the acquisition of spectra of preselected 
single points within the sample, it is also possible to scan a whole area at a defined pixel 
resolution and generate a spectral map in which every pixel is defined by a separate 
spectrum. This technique enables to acquire Raman images of a defined area.  
ground state
Stokes
scattering
Anti-Stokes
scattering
Rayleigh
scattering
vibrational state
virtual energy level
fluorescence NIR
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Figure 4. Technical setup of Raman spectroscopic measurements. Tissue or isolated cells placed on 
the sample holder are excited by a green (532 nm) or near infrared (785 nm) laser (green light path). 
Photons of lower frequency are emitted, separated from Rayleigh or higher frequency scattering by a 
notch filter and detected by the CCD camera in the spectrograph (pink light path). The bright field micro-
scope setup allows for targeting the region of interest for Raman acquisition (yellow light path). Single 
point spectral acquisition or Raman imaging can be performed. Adapted from Marzi et al. (Acta Biomateri-
alia, in revision). 
Raman spectra provide qualitative and quantitative information on defined molec-
ular bonds and the Raman fingerprint is specific for a certain structure. However, 
whereas small molecules and chemicals provide singular specific and defined peaks, 
large biomolecules in cells or tissues mostly represent a higher number of molecular 
vibrations and assigned peaks. Different proteins or lipids that predominantly exhibit 
similar functional groups can show small spectral differences. Thus, multivariate data 
analysis (MVA) tools 98, 99, such as principal component analysis (PCA), linear discrimi-
nant analysis, cluster analysis or regression models, can be applied to identify minor 
spectral differences and analyze complex and large data sets. PCA was the method of 
choice for the analysis of the Raman measurements presented in this work. PCA is a 
vector-based approach to reduce dimensionality 100, 101 and is commonly applied in 
chemometrics. A PCA is based on the following assumption 102: 
(1)     [%] 	= [)]	*+,-	 + 	 [/]			
X:	data	matrix	
T:	scores	matrix	
PT:	matrix	of	loadings	
E:	residuals	
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A data matrix (X) consists of the most dominating principal component scores (T) 
and their corresponding loadings matrix (PT). The matrix E are residuals that are irrele-
vant for the variability or represent noise 103. In PCA the spectral information is reduced 
to eigenvectors, so-called principal components (PCs), that explain the variance be-
tween the spectral data and are orthogonal towards each other 103. Thus, PC1 explains 
the main spectral differences, PC2 the next relevant variability and so on. However, de-
pending on the data pretreatment and measurement conditions, PC1 of spectral data 
often describes discrepancies in the baseline and does not describe sample-specific 
information. To visualize the spectral data analyzed by PCA the scores plot allows to 
show each spectrum as a score value in a two-dimensional scatter defined by two se-
lected PCs. The scores plot defines whether there is a separation between two or more 
data sets. Another output of the PCA, that helps to interpret the data is the loadings plot. 
The loadings plot explains spectral differences that are indicated by the corresponding 
PC 99. Positive peaks in the loadings plot refer to spectral information that are predomi-
nantly found in spectra of a positive score value. Negative peaks in the loadings correlate 
to spectral information of data points with negative score values.  
Raman imaging is dominantly applied to visualize the distribution and localization 
of defined structures in a sample. For in-depth analysis of the overall data set and to 
assess information of a region of interest within the measured area, techniques for data 
reduction and preselection are required. Data analysis of Raman images is more com-
plex than single point measurement analysis due to the big data sets. Spectral maps 
allow to construct Raman images and can be evaluated by creating intensity heat maps 
of a defined Raman shift bandwidth or by MVA 104. An additional approach similar to 
PCA is true component analysis (TCA) that originates from the image analysis of the 
WiTec Project FIVE software (WiTec GmbH, Ulm, Germany). TCA creates an intensity 
distribution image by either manual selection of a spectrum of interest in the spectral 
map or a reference spectrum or by defining the most prevalent spectral components by 
basis analysis. A measured spectrum (Si) is described based on a linear combination of 
known spectra (B). 
(2)     F⃗H = IJKL⃗ H + / 
   F⃗H:	spectrum	from	the	spectral	data	set	
	 	 	 IJ :	matrix	of	basis	spectra	
	 	 	 KL⃗ H:	mixing	values	spectrum	i	
	 	 	 /:	error	spectrum	
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1.2.3 Approaches of Raman Microspectroscopy in Biomedical Research 
Raman microspectroscopy and imaging have certain advantages that overcome 
the limitations of commonly used optical or histochemical techniques. In comparison to 
NIR spectroscopy this technique is not significantly affected by water 86 and is advanta-
geous for the analysis of samples in aqueous solutions. Moreover, it enables an ade-
quate spatial resolution as well as real-time acquisition times. Different than in fluores-
cence microscopy and histochemistry, no specific labeling is required which allows for 
non-destructive measurements. Raman techniques are well-established for qualitative 
and quantitative applications in pharmaceutical and material science 105-108. Although 
early approaches already introduced Raman spectroscopy for biological applications to 
investigate molecular orientation and arrangement in polymers or proteins 109-111 and for 
bioanalytics 112, 113, Raman microspectroscopy still needs to further evolve in the analy-
sis of complex biomolecular composites such as tissues and cells as well as in biomed-
ical approaches. 
In the biomedical field, Raman techniques are popular in the distinction between 
healthy and diseased tissues in cancer research 114-116. Furthermore, variable cells such 
as bone cells, cancer cells, stem cells 117-120 as well as cardiomyocytes differentiation 
121, 122 and cell death stages 97, 123 have been analyzed and characterized by Raman 
spectroscopy. Due to its broad usability Raman spectroscopy offers constantly increas-
ing fields of applications. However, in the research area of cardiovascular tissues and 
cells only few Raman-based studies were performed. Most of the studies focused on the 
detection of calcifications in vessels or heart valve tissues. The phosphate in apatite 
provides a strong and specific Raman signal at 960 cm-1 that indicates calcific lesions 
and atherosclerosis 124-126. Analysis of heart valve collagen structures has first been in-
vestigated by Votteler et al., who monitored tissue degradation by collagenases 127. Be-
sides the applications in tissues, Raman spectroscopy can be applied in the analysis of 
coatings of mechanical heart valves due to its properties in material characterization 128, 
129. In TE, Raman microspectroscopy is well-recognized for biomaterial characterization 
87, 130, whereas the potential to detect neo-tissue formation, degradation and cell-bio-
material interaction requires further investigation. 
Another advantage of Raman microspectroscopy are the comparably high pene-
tration depths. Thus, it can be applied for permeation studies of strong scattering drugs, 
chemicals or carbon nanotube (CNT)-coupled substrates that present a high vibrational 
contrast into weaker scattering tissue 131. In vivo imaging of drug delivery through skin 
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132, 133 or the assessment of skin penetration depths of sunscreen 134 have been per-
formed using Raman microspectroscopy. Semi-quantitative assessment of chemicals 
such as DMSO and PG that are applied as well as CPAs in cryopreservation medium 
were demonstrated in skin penetration studies 135-137.  
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1.3 Multiphoton Imaging 
Laser-induced multiphoton excitation imaging is a non-linear optical process. 
Non-linear optics refer to a higher-order response of the dielectric polarization to the 
electrical field of the light and are based on pulsed lasers 138. Multiphoton microscopy 
provides several advantages for biological imaging, such as reduced photobleaching of 
the sample, an increased confocal penetration depth due to the application of femtosec-
ond NIR lasers and fast, label-free imaging of intrinsic fluorescent or multiphoton-active 
molecules in ECM and cells 139, 140.  
In multiphoton microscopy, it can be distinguished between two-photon excited 
fluorescence (TPEF), also referred to as multiphoton-induced autofluorescence, and 
second harmonic generation (SHG). TPEF is based on simultaneous absorption of two 
photons of the same frequency and results in the non-linear excitation of fluorescence 
in molecules. In TPEF, the emission wavelength is higher than half of the incident fre-
quency (>l/2). Originally, it was introduced to overcome strong scattering light in fluo-
rescence microscopy of tissues and in combination with fluorescent dyes 141. However, 
label-free imaging is accessible for endogenous fluorescent molecules in tissues and 
cells such as NAD(P)H, elastin or flavins 139, 142. SHG imaging is based on the simulta-
neous excitation with two photons of the same frequency, resulting in a sharp emitted 
signal of exactly half of the incident wavelength (=l/2) 143. In SHG the input energy re-
mains constant, whereas in TPEF a loss of energy caused by the relaxation of the ex-
cited state is observed 144. SHG imaging requires non-centrosymmetric molecules to 
achieve an interaction with the laser photons. Collagen, microtubules and skeletal mus-
cle have been reported to be SHG-active 145-147. Assessment of ECM structures is of 
major interest in multiphoton microscopy. Collagen fibers and elastic fibers in tissues 
can be imaged simultaneously by inducing TPEF signal of elastic fibers and SHG in 
collagen fibrils 142, 148. Signals can be separated by two different band-pass filters and 
detectors 146.  
Multiphoton imaging evolved quickly and has widely been applied to study colla-
gens in diverse tissues. Multiphoton imaging is well-established in imaging of skin or 
cancer tissues 144, 149, 150. Furthermore, it has been shown to be suitable as an in vivo 
device due to the penetration depth as well as in an endoscopic format 151-153. Moreover, 
multiphoton microscopy demonstrated the detection of structural deteriorations in colla-
gen fibers of heart valve leaflets 154. Multiphoton imaging, which was already established 
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for collagen and elastic fiber imaging in cryopreserved heart valve tissues 50, 55 was ap-
plied in addition to Raman microspectroscopy as proof of principle technique. Imaging 
of the collagen-rich fibrosa and the elastin-rich ventricularis allows to characterize 
changes in the ECM structures. Collagen fibers in the fibrosa of fresh native heart valve 
leaflets show parallel alignment (Figure 5 A, C), confirming the circumferential alignment 
of collagen fibers described in literature 50, 155, 156. Collagen bundles in the ventricularis 
are less oriented and loosely arranged (Figure 5 B, D). Elastic fibers in the fibrosa are 
aligned in parallel to the collagen fibers, whereas in the ventricularis elastic fibers form 
a fiber network. In addition, cells are detectable in the elastic fiber signal channel by 
endogenously fluorescent NADPH (Figure 5 A, C). Ovine and porcine leaflets are com-
monly used as animal heart valve replacement tissues. Both leaflet structures are com-
parable in their multiphoton signal intensity. Similar structural collagen and elastic fiber 
patterns are found in fibrosa and ventricularis. Slightly thicker fibrosa collagen bundles 
are shown in porcine tissues. 
 
 
Figure 5. Multiphoton imaging of a native heart valve leaflets. Merged multiphoton images of collagen 
(green) and elastic fibers (red) in fibrosa (A, C) and ventricularis (B, D) layer of native ovine (A, B) and 
porcine (C, D) pulmonary leaflets. Cells were detectable in the elastin channel (indicated by arrows). Scale 
bar equals 60 µm 
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2 Objectives of the Thesis 
 
This thesis focuses on the application of Raman microspectroscopic methods for the 
quality assessment and monitoring of cardiovascular cells and tissues. The aim was to 
establish Raman imaging and Raman single point measurements in cardiovascular re-
search to provide molecular information on extracellular matrix (ECM) and cellular com-
position. Conventional techniques to determine gene or protein expression lack marker-
independence and non-destructiveness. Thus, the usability of Raman microspectros-
copy as non-invasive quality control tool to identify and distinguish cardiovascular cells, 
tissues and tissue-engineered constructs, according to their specific Raman fingerprint, 
was explored. In particular, Raman microspectroscopy was applied in two different ap-
proaches of cardiovascular replacements. The quality assessment of an alternative ice-
free cryopreservation (IFC) procedure in transplantation of heart valve leaflets and the 
characterization and monitoring of SMCs that are applied in various vascular tissue en-
gineering approaches were addressed.  
IFC leaflets showed better preserved ECM structures and immunogenicity in vitro 
when compared to frozen cryopreserved (FC) leaflets. Therefore, this work attempted 
the investigation of long-term (12 months) in vivo sustainability of IFC- and FC-treated 
heart valve leaflets and the monitoring of IFC treated porcine xenograft performance in 
a sheep model. Collagen fibers, as a major ECM protein and load-bearing component, 
were in the focus of the analyses of structural deteriorations. In addition, a quantitative 
approach to monitor potentially toxic cryoprotective agents (CPAs) of the IFC medium in 
heart valve tissues was investigated. The sensitivity of Raman microscopy and imaging 
to detect interstitial CPA concentrations was assessed based on a multivariate calibra-
tion model. 
Moreover, Raman imaging and Raman single point measurements were established 
to characterize human smooth muscle cells (SMCs). The goal was to identify and mon-
itor phenotypic switching in SMCs by Raman microspectroscopy and to determine the 
sensitivity to distinguish SMCs of different tissue origins and compare the results to 
standard techniques such as immunohistochemistry and quantitative PCR. Finally, Ra-
man spectroscopy was tested as quality control tool in tissue engineering of vascular 
SMC rings to determine the influence of different culture conditions on ECM remodeling 
and to compare the designed constructs to the structures of native vascular tissue. 
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3 Results I: Characterization of Heart Valve ECM Structures 
Standard cryopreservation of heart valves has been shown to result in a distinct 
immune response, inflammation and ECM degradation 15. Thus, transplants are predis-
posed to calcification and lack long-term performance, which is particularly critical in 
pediatric patients. IFC is an alternative cryopreservation technique that avoids ice-crys-
tal formation. A previous short-term study provided preliminary results on IFC leaflet 
performance 55. In comparison to FC leaflets, IFC tissues showed superiority in hemo-
dynamics and preserved ECM structures, detected by multiphoton imaging and histo-
chemical staining 55. For in-depth analysis of molecular changes in the leaflet’s ECM, 
Raman microspectroscopy was established as a marker-independent, non-invasive 
technique. All tissues samples for the analyses were acquired within sheep studies, con-
ducted to assess long-term performance and immunogenicity of IFC treated pulmonary 
allografts (ovine) and xenografts (porcine). Explanted, treated non-transplanted tissues 
as well as native tissues of the replacement surgeries were analyzed. 
 
3.1 Raman Spectrum of the Heart Valve Leaflet’s ECM 
Standard histochemical techniques allow for the identification and localization of 
ECM structures. However, these techniques do not enable characterization on the mo-
lecular level. Raman microspectroscopy was established to define biochemical changes 
of the ECM. Before assessing the influence of cryopreservation and implantation on 
heart valve leaflets, Raman spectra of native ovine and porcine pulmonary leaflets were 
acquired as reference spectra to later be compared with xenographic and allographic 
implants. The ECM and its diverse components are essential for the leaflet’s integrity, 
function and durability. Collagens present a major component of the heart valve’s ECM 
and are crucial for the leaflet’s biomechanical strength and durability 22, 154. Therefore, 
spectral acquisition focused on the collagen bundles in the fibrosa layers of the heart 
valve leaflets, that could be targeted over the bright field camera function of the Raman 
microscope. Compared to a collagen I (Col I) reference spectrum, both spectra showed 
assignments to the most characteristic Col I peaks, confirming Col I as major collagen 
in the leaflets ECM. Minor differences were detected in the spectral fingerprint of ovine 
and porcine collagen fibers (Figure 6 A). PCA revealed a clear clustering between the 
two animals (Figure 6 B). Spectral discrepancies were mainly identified as an intensity 
difference at 872 cm-1 and peak shifts at 942, 1243 and 1454 cm-1 (Figure 6 C). Positive 
peaks in the loadings plot showed a major influence on data in the positive score range, 
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negative peaks explained characteristic peaks of data defined in the negative score 
range of the PC. Ovine data, which clustered in the positive PC1 range, showed higher 
ratios in the hydroxyproline peak at 872 cm-1. Hydroxy groups in hydroxyproline form 
stereoelectronic bonds and are essential for the constitutional stability in collagen 3D 
structure 157, 158. This might indicate a stronger collagen fiber folding in ovine compared 
to porcine tissues and correlates to mechanical testing data of ovine and porcine aortic 
leaflets reported by Martin et al that demonstrated a higher degree of extensibility for 
ovine leaflets 159. Other minor differences were visible in peak shifts in porcine tissue in 
the amide III region (1243 cm-1) and in the collagen backbone (942 and 1454 cm-1). 
 
 
Figure 6. Raman microspectroscopy on native heart valve leaflets. (A) Average Raman spectra of 
the collagen structures of the fibrosa layer of native ovine (red) and porcine (blue) tissues. The reference 
spectrum of collagen I is shown in grey. (B) PCA showed a clear separation of porcine and ovine data, 
explained by alterations in the indicated peaks in the PC1 loadings plot (C).  
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3.2 Long-term Performance of IFC and FC Treated Leaflets 
Preclinical as well as mid and short-term studies could show superior perfor-
mance and persistence of IFC treated tissues in comparison to FC tissues 52, 55. A long-
term animal study was conducted to assess the effects of implantation on cryopreserved 
allografts and their in vivo durability over time. Leaflets preserved by FC or IFC proce-
dure were implanted in sheep for 12 months. To evaluate and compare the effects of FC 
and IFC treatment in long-term transplantation, leaflets were explanted after 12 months 
in vivo and analyzed. 6 FC and 5 IFC heart valves, respectively, were analyzed by stand-
ard histochemical staining for immune response (CD3, chloroacetate esterase), calcifi-
cation (van Kossa), cellularity and morphology (Movat-Pentachrome, Hematoxylin-Eo-
sin), as well as echocardiography for functional testing of the valves as described before 
50, 55, 160. In addition, Raman microspectroscopy was applied as novel approach to non-
invasively and marker-independently analyze changes in the leaflets ECM structures. 
Histochemical analysis revealed inflamed, T-cell infiltrated and thickened leaflets 
in 3 of 6 FC tissues. Cardiovascular imaging showed excellent hemodynamic data for 
IFC leaflets (Biermann and Marzi et al., Appendix I). For fast assessment of ECM con-
dition, multiphoton images of each explant and native controls were acquired. Collagen 
bundles are SHG-active and by separating two detector channels with different band-
pass filters elastic fibers were simultaneously detectable due to their auto-fluorescence. 
Native and explanted IFC and FC leaflets were compared. Collagen and elastic fibers 
were imaged in all tissues. In comparison to the analysis of non-transplanted porcine 
pulmonary leaflets and a mid-term sheep study, that both reported significantly weaker 
collagen and elastin signals in FC leaflets 50, 55, long-term implanted FC leaflets showed 
clearly detectable collagen and elastin structures. Qualitative differences in collagen and 
elastin expression were not identified in the ventricularis for any of the treatments. Alter-
ations in the collagen fiber structures were of major interest. For qualitative analysis, 
crimp amplitude and crimp period of the collagen fibers were defined in the SHG images. 
Crimp structure is an indicator for collagen fiber durability. Worn-out, stretched and elon-
gated collagen fibers that show a reduced extensibility have been reported in relation to 
failure in withstanding biomechanical stress and heart valve aging 155, 161, 162. No signifi-
cant difference was detected in native and IFC crimp period and amplitude. Explanted 
FC tissues exhibited a significant decrease in crimp amplitude and an increase in crimp 
period (Biermann and Marzi et al., Appendix I, Figure 5), indicating an elongation and 
degeneration of the collagen fibers as shown as well for elongated and stretched mitral 
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valve leaflets by Lee et al. 163. Altered crimp structures in FC explants were a result of 
the incapability of the leaflets to withstand biomechanical strain leading to long-term fail-
ure. 
Multiphoton imaging assessed collagen fiber deterioration and structural 
changes. Raman measurements and analysis helped to identify changes on a molecular 
level. No spectral intensity differences in the overall Raman fingerprint were found in 
native, IFC and FC tissues. In comparison to induced degradation of porcine heart 
valves with collagenase performed by Votteler et al 127, the overall collagen content in 
ovine tissue did not decrease due to the FC treatment. PCA of the spectral data of five 
or six heart valves per group could identify spectral differences between FC and native 
data. IFC data did not cluster significantly from the native ECM data (Biermann and 
Marzi et al. Appendix I, Figure 6). PC2 described the separation between native, IFC 
and FC data. Comparison and statistical analysis of the PC2 score values showed a 
significant difference between native and FC data. Major peaks involved in the spectral 
differences were described by the PC2 loadings plot and were assigned to defined mo-
lecular bonds within the collagen molecule correlating to structural reorganization in 
crosslink and 3D structure (Biermann and Marzi et al., Appendix I, Figure 6). PC3 indi-
cated a minor, however not significant separation of IFC and native data. Relevant peaks 
in the PC3 loadings plot were 817, 863 and 941 cm-1 that referred to C-C bonds of the 
collagen backbone. Increased peak intensities in IFC tissues might indicate changes in 
the secondary structure and in the alignment of the collagen fibers 164. These findings 
correlated to histological results that presented condensed fiber structures in IFC ex-
plants. In-depth spectral analysis revealed a peak shift in the amide I peak region. The 
average Raman fingerprint spectrum of FC leaflets had a maximum peak around 1664 
cm-1, whereas native and IFC leaflets had a maximum at 1666/1667 cm-1, comparable 
to the amide I peak in Col I. Similar findings were reported in studies on tendon and 
bone, describing a decrease in collagen amide I Raman shift wavenumber with increas-
ing mechanical or thermal strain 165, 166. 
We conclude, that FC leaflets, due to the deteriorations caused by the cryopres-
ervation, do not sustain the biomechanical stress in vivo, resulting in structural reorgan-
ization in the triple helical collagen structures, which were shown by altered crimp struc-
tures in multiphoton imaging and amide I peak shift in Raman spectra. Over the long 
term, this led to functional failure of the implants. Collagen in FC ovine heart valves was 
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more restructured and remodeled than degraded. Supportively, Collagen I ELISA of ho-
mogenized IFC and FC tissues did only show a minimal, but not significant decrease in 
FC collagen content compared to collagen in IFC leaflets (Biermann and Marzi et al., 
Appendix I, Figure 6). An additional ELISA on metalloproteinase 9 (MMP 9), a gelati-
nase that is involved in collagen degradation 167, did not show a significant increase in 
FC tissue homogenates compared to IFC leaflets and confirmed our conclusion that FC 
matrix changes occur as mechanically-induced deteriorations rather than collagen deg-
radation. Although there is no indication for an overall matrix degeneration in FC leaflets, 
deteriorations might have an essential influence on the functionality of the implants, as 
it has been reported previously that alterations in collagen crosslink have a stronger 
impact on mechanical strength of heart valve tissue than the collagen content itself 22. 
Notably, FC functional and hemodynamic results showed a similar or even slightly 
better outcome than in short and mid-term studies, indicating a partially reversible re-
covery in vivo. An additional PCA comparing native, non-transplanted leaflets and long-
term explants confirmed this hypothesis. PCAs for IFC and FC data, showed a separa-
tion of non-transplanted and native tissue spectral data for both, FC and IFC treated 
leaflets (Figure 7). Whereas, IFC tissues recovered in vivo and presented ECM spectral 
information overlapping the data of native leaflets (Figure 7 B), FC explant data only 
slightly shifted towards native ECM score values in PC2 (Figure 7 A). ECM damages 
caused by the cryopreservation method were irreversible and did not fully recover. More-
over, a distinction between native and long-term implanted FC tissues appeared in PC3, 
indicating additional occurrence of matrix deteriorations during implantation, which might 
influence the long-term performance of FC leaflets. 
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Figure 7. PCA of native, treated non-transplanted and long-term implanted FC and IFC tissues. 
Both FC and IFC treatments induced significant tissue alteration that were irreversible in FC tissues (A) 
and reversible in IFC implants (B). 
Diverse analyses confirmed that IFC resulted in acellular, fully functional leaflets 
with reduced immunogenicity and well-preserved matrix structures after 12 months in 
vivo. Raman microspectroscopy and multiphoton imaging could confirm that IFC treated 
ECM structures of the implants obtained an integrity and architecture comparable to 
native valves. In contrary, FC treated leaflets presented deteriorations and degeneration 
of their collagen fiber structures, that might cause a limited biomechanical strength and 
shortened lifetime in vivo. Moreover, Raman microspectroscopy enabled in-depth anal-
ysis of structural changes in FC leaflets on a molecular level, allowing for a better un-
derstanding of the damaging effect of the FC method on heart valve tissue.  
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3.3 Detection of Inflammation-driven Changes in Xenografts 
Transplantation of cryopreserved allografts or homografts is commonly applied in 
clinics. However, there is limited availability of donor tissues, especially in pediatrics 168. 
Xenotransplantation might be an alternative option to overcome this obstacle and pre-
vent donor organ scarcity. Therefore, IFC that previously showed improved tissue 
preservation in allografts, was applied on xenografts to evaluate their in vivo perfor-
mance and immune responsiveness. A large animal study was conducted over a period 
of 12 weeks. IFC treated allografts or xenografts (porcine) were implanted in 12 juvenile 
merino sheep. Leaflets were explanted after six different time points between 1 and 12 
weeks. In order to determine IFC xenograft immune response and acceptance, immuno-
histochemistry, ex vivo CT and a transforming growth factor beta (TGFb) release assay 
were conducted. 
Allografts were acellular at all time points of explantation. In contrary, xenografts 
which were acellular in the first explants, were infiltrated by T-cells and evolved a distinct 
thickening and inflammation over time. Severe immune responses were detectable in 
xenogeneic leaflets from 4 weeks on. TGFb release was slightly increased in xenografts, 
but no significant time-dependent release was shown (Biermann et al., Appendix II, 
Figure 4-6). 
Moreover, multiphoton imaging and Raman microspectroscopy were employed 
for additional assessment of ECM integrity. Multiphoton imaging of native ovine and por-
cine tissues and xenografts and allografts explanted after 2 and 12 weeks showed sim-
ilar collagen and elastin structures (Biermann et al., Appendix II, Figure 7). No deterio-
ration or changes in ECM structures were detectable in either sample. Multiphoton im-
aging did not detect any visible effects of IFC treatment on the xenograft matrix. How-
ever, in contrary to allografts, xenografts showed cells in the multiphoton images, indi-
cating a migration of immune cells.  
Raman microspectroscopy was applied to assess detailed molecular changes in 
the xenogeneic leaflets. It was shown that native ovine and porcine leaflets differed in 
their Raman biochemical fingerprint. Therefore, prior to the analysis of the explants, IFC 
treated but non-transplanted ovine and porcine tissues were measured. Comparison of 
these xenografts and allografts with native porcine and ovine tissues indicated different 
effects of the cryopreservation procedure on porcine and ovine tissues. PCA analysis 
showed a clustering of all four groups (Biermann et al., Appendix II, Figure 8). Besides 
the differences in native ovine and porcine tissue described by PC3, differences were 
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shown between treated non-transplanted and native leaflets within xenografts and allo-
grafts in PC2. Interestingly, clustering between porcine tissues was more significant than 
the separation of treated and untreated ovine data. PC2 loadings described a spectral 
assignment similar to the general heart valve collagen spectrum. Thus, differences in 
native and IFC treated leaflets were explained by intensity differences in collagen. IFC 
treated leaflets clustered in the negative PC2 range correlating to higher collagen con-
tents. IFC eliminated interstitial water based on the cryopreservative effect and caused 
shrinking of the leaflet and condensation of the fiber structures, as shown in histochem-
ical analysis (Biermann and Marzi et al., Appendix I, Figure 2). Accordingly, the overall 
collagen content did not increase due to IFC treatment, but as a consequence of the 
fiber condensation the relative spectral intensity of collagen fibers increased. This effect 
seemed to be stronger in porcine than in ovine leaflets. Those results postulate that 
porcine tissues are more sensitive to structural alterations caused by the cryopreserva-
tion procedure than ovine tissues. These findings were confirmed by previous results of 
Votteler et al 127 and Schenke-Layland et al 52, who described collagen degradation in 
FC treated porcine heart valve tissues by Raman microspectroscopy as well as mul-
tiphoton imaging. In contrary, ovine FC treated tissues only showed collagen deteriora-
tion, but no decrease in overall collagen signal intensity (Biermann and Marzi et al., 
Appendix I, Figure 5). Peaks of the PC3 loadings plot that caused the separation of 
ovine and porcine spectral data were similar to the assignments already described in 
the PCA of only native porcine and ovine tissues. 
For analysis of xenograft immune response, leaflets were explanted after time 
points of 1, 2, 3, 4, 8 and 12 weeks in vivo and measured by Raman microspectroscopy 
within 48 h after excision. One allograft (4 weeks) required explantation after 2.5 weeks 
due to a severe inflammation (pneumonia) in the animal. Xenograft and allograft spectra 
were compared separately to detect time-dependent changes in each graft type. PCA of 
allograft samples showed spectral differences in PC3 (Biermann et al., Appendix II, 
Figure 6). Comparison and statistical analysis of the PC3 scores plot showed significant 
differences between native leaflets and tissues within the first 3 weeks after transplan-
tation. Allografts implanted for 8 and 12 weeks did not differ in their Raman data from 
native tissues (Biermann et al., Appendix II, Figure 6). Allografts underwent reversible 
matrix changes that might correlate to the condensation caused be the cryopreservation 
and recovered during implantation time. These results were equally shown for long-term 
implanted allografts, as described above (Figure 7 B). 
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PCA of xenografts demonstrated time-dependent spectral differences in PC1 
(Biermann et al., Appendix II, Figure 6). Score values of the explants differed signifi-
cantly from native porcine tissue with decreasing score values over time. While non-
transplanted and leaflets explanted within the first week showed higher score values 
than native leaflets, leaflets explanted after 3 weeks or later demonstrated negative 
score values. Differences within the first weeks were dominated by higher collagen sig-
nals explained by the condensed ECM structures. Differences of mid-term explants are 
related to immune reaction-triggered matrix degradation. The shift in PC score values at 
a time point between 3-4 weeks correlated to the reported T-cell-mediated immune re-
sponse and tissue degeneration in xenografts after 4 weeks. 
Immunohistochemical staining and Raman analysis results showed that IFC 
treated xenografts demonstrated an initially unremarkable immunogenicity, but failed in 
mid-term performance and were actively rejected. Raman spectra of the xenografts ECM 
identified significant alterations at the same time point as severe T-cell infiltration and 
inflammation were detected. An association of ECM degeneration and T-cell infiltration 
in bioprosthetic xenografts has been previously reported 169. Raman results of treated 
but non-transplanted xenografts and allografts indicated a significantly higher effect of 
the cryopreservation procedure on porcine tissue. Xenogeneic leaflets exhibited inferior 
ECM integrity before transplantation and could not recover fast enough in vivo before 
exposure to additional stress by infiltrating immune cells.
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4 Results II: Quantitative Assessment of CPAs in Heart 
Valve Tissues 
 
IFC treatment of heart valves has been shown to improve leaflet ECM preserva-
tion compared to standard cryopreservation. The main difference between the two treat-
ments is the cryopreservation media. FC medium contains 10% DMSO (1.4 M), while 
IFC medium (VS83) consists of 4.65 M DMSO, 4.65 M FMD and 3.31 M PG in Euro-
Collins buffer (EC). CPA concentration in IFC medium is almost about 10 times higher 
than in the standard freezing solution and therefore enables ice-free cryopreservation 
and storage below the glass-transition temperature of the CPAs. Despite the advantages 
of highly concentrated CPAs in IFC medium that sustain the leaflets long-term integrity, 
the safety issue of CPAs needed to be addressed before releasing IFC treated heart 
valves for clinical trials. All CPAs in VS83 cryomedium, applied in IFC, are molecules 
that are potentially toxic 170-173 and could harm the patient directly or cardiovascular cells 
that should help to remodel the implanted tissue. Therefore, a complete removal of CPAs 
needed to be guaranteed by the washing protocol before implantation. To date, for quan-
titative assessment of CPAs or other drugs in tissues, complex quantitative techniques 
such as high performance liquid chromatography (HPLC) 174, tandem mass spectrome-
try (MS) 175, 176 or nanoparticle-coupled magnet resonance imaging 177 are established 
that would not allow for a marker-independent, non-invasive and real-time monitoring of 
chemicals or drugs in tissues. Raman microspectroscopy and Raman imaging were es-
tablished for qualitative and quantitative in situ analysis of residual CPAs in IFC treated 
heart valve tissues. The washing procedure consists of 5 washing steps of 10 min in EC. 
To determine the CPAs in the washing solution, supernatants of the washing steps of 
the long-term study (see Chapter 3) were collected and measured. In addition, Raman 
imaging was performed on IFC treated leaflets directly after rewarming to monitor the 
CPAs that penetrated the tissue and their decrease due to the washing procedure. More-
over, in order to define the limit of detection of the CPAs in heart valve tissues, leaflets 
stored in different VS83 concentrations were measured by Raman microspectroscopy. 
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4.1 Raman Spectra of CPAs in VS83 Medium 
In comparison to large biomolecules in tissues and cells that mostly consists of 
similar amino acids, chemicals and small molecules represent well-defined singular Ra-
man peaks. Single components of the VS83 solution were measured separately to iden-
tify the spectral assignments of DMSO, FMD and PG and their most significant specific 
peaks that could later be used for the establishment of a calibration model. The most 
significant peaks of VS83 spectrum were found at 677 and 711 cm-1 and correlated to 
the symmetric and asymmetric stretch of the C-S bonds in DMSO. Specific peaks for 
PG were found at 806 and 840 cm-1 and were assigned to CH3–bending and C-C-O 
stretching in PG. CH rocking in FMD caused a characteristic peak at 1392 cm-1 (Marzi 
et al., Appendix III, Figure 1). The Raman spectrum of the EC medium did not show 
signals in the wavenumber range of DMSO. A slight shoulder appeared in the higher 
wavenumber region of the PG range and a weak peak slightly shifted to the maximum 
of the FMD peak was detectable. However, these peaks were of marginal importance, 
because the overall peak intensities of the pure CPAs were between 20 (compared to 
FMD) to 60 (compared to DMSO) fold higher than the intensities in EC. These specific 
peaks enabled a simultaneous monitoring of all CPAs. 
 
4.2 CPA Quantification in Supernatants  
The collected washing supernatants of the five washing steps and the storage 
solution of 6 IFC heart valves were measured. Average Raman spectra demonstrated 
significantly decreased CPA intensities after the first washing. For quantitative assess-
ment of the CPAs and the establishment of a calibration model, fresh VS83 solution was 
diluted with 1xEC. Calibration solutions ranged between 100% and 0.2% VS83, corre-
sponding to concentrations of 0.009-4.65 mol/l for DMSO and FMD and 0.007-3.31 mol/l 
for PG. A partial least square regression model allowed for the prediction of the overall 
VS83 concentration. However, in order to consider different wash-out kinetics of the 
three CPAs a separate calibration for every CPA was established according to their spe-
cific Raman shift ranges (Marzi et al., Appendix III, supplementary figure 1). The con-
centrations of each CPA within the supernatants were predicted over the calibration 
model. Results showed a significant decrease for DMSO, PG and FMD after the first 
and between the first and the second washing step. After the third washing step initial 
DMSO and PG concentrations in the supernatants decreased by 99.2% and FMD de-
creased by 98.9%. The following washing steps did not indicate a further change in CPA 
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content. Final concentrations in the supernatants of the last washing step represented 
0.02 M DMSO, 0.01 M PG and 0.04 M FMD (Marzi et al., Appendix III, Figure 2). The 
washing protocol showed sufficient efficacy to remove the CPAs. Quantitative analysis 
of CPA concentrations in the supernatants indicated no significant release of DMSO, 
FMD and PG after the third washing step. Thus, the results encouraged to shorten the 
protocol to 3 instead of 5 washing steps. 
 
4.3 In situ CPA Detection in Tissue and Analysis of Tissue Permeability 
Raman microspectroscopy had the fidelity for the quantitative analysis of DMSO, 
FMD and PG in the washing supernatants up to concentrations in the single-digit mM 
range. There exist several techniques which allowed for the quantification of chemicals 
or drugs in liquids or were used to study CPA permeation kinetics in different tissues 
such as nuclear magnetic resonance, osmolality measurements or capillary zone elec-
trophoresis 178-182. However, for the establishment of an in situ tool to non-invasively 
monitor chemical residuals within tissues, all of these techniques lacked in either speci-
ficity, non-destructiveness or sensitivity. In addition, the previous studies showed that 
permeation kinetics strongly depended on concentration, temperature, the applied CPA 
as well as the treated tissue. To circumvent these variables and avoid the mathematical 
modeling of penetration kinetics, an in situ quality control tool for direct assessment of 
CPA concentration in tissues would be beneficial. Therefore, Raman techniques were 
applied. To test the applicability for CPA detection within tissues, single Raman spectra 
acquisition and Raman imaging were performed. The Raman fingerprint of IFC treated 
tissues prior and after the washing procedure was compared. Freshly rewarmed IFC-
treated leaflets demonstrated peaks in their biochemical fingerprint, that did not correlate 
to the leaflets ECM structures, but were assigned to the previously defined peaks of 
DMSO and FMD. PG was not clearly detectable due to the overlap with peaks assigned 
to the leaflets ECM (Marzi et al., Appendix III, Figure 3A). For in-depth analysis and 
monitoring of the washing procedure, the washing process was simulated and continu-
ously imaged by Raman microspectroscopy. Image acquisition at very low resolution 
allowed for fast scanning of a large area. Within 3 min, it was possible to collect an 
overview image of an area of 2000 x 2000 µm. Detailed tissue structures were not de-
tectable at the low pixel resolution of 100 x 100 µm, however it was sufficient for specific 
identification of the CPA spectra. Efflux of every CPA could be monitored in the intensity 
heat maps at the characteristic Raman shift regions of 640-740 cm-1 for DMSO, 780-860 
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cm-1 for PG and 1280-1400 cm-1 for FMD. Significant signals from CPAs were not de-
tected after the third washing step (Marzi et al., Appendix III, Figure 4). However, within 
the first washing step different efflux kinetics for DMSO, FMD and PG were detected. 
For the next washing steps a highly significant decrease was detected for all CPAs. 
Significant differences between the different CPAs within a washing step were only de-
tected between DMSO and PG (Figure 8). In summary, DMSO was washed out the 
fastest, followed by FMD and then PG. Those results corresponded to the room temper-
ature penetration kinetics of IFC medium into fresh leaflet tissue reported by Vasquez-
Rivera et al. 183.  
 
 
Figure 8. Raman monitoring of the CPA efflux. Statistical analysis of the normalized spectral intensities 
of the CPAs at the different washing steps showed a significant decrease after each washing step. A 
significant difference in the kinetics of the different CPAs was observed between DMSO and PG. n=3; 
*p£0.5, **p£0.05, ***p£0.01 for differences between the washing steps; #p£0.5 for differences between 
the CPAs 
A PCA of the images of each washing step could identify both CPAs and tissue 
structures (Marzi et al., Appendix III, Figure 5A). Raman images of the freshly rewarmed 
leaflets and the leaflets after the first washing step were dominated by spectral infor-
mation in the positive PC range that was assigned to the CPAs. Contrarily, Raman im-
ages after the second washing steps mainly provided spectral information relating to the 
leaflets ECM (Marzi et al., Appendix III, Figure 5B). Raman imaging results confirmed 
the outcome of the quantitative analysis of the supernatants and the proposal to shorten 
the washing procedure. 
An additional experiment was conducted to determine the limit of detection of 
CPAs in tissues. Therefore, single leaflets, obtained from the replacement surgeries, 
were preserved in different concentrations of IFC medium, rewarmed and measured by 
single spectra acquisition. Concentrations varied between 100% VS83 with the known 
#
#
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CPA concentrations and 5% VS83 corresponding to CPA concentrations of 0.23 M 
DMSO and FMD and 0.17 M PG. Significant interstitial DMSO peaks were detectable 
for all concentrations as well as minor FMD peaks. PG was not detectable in the lower 
VS83 concentrations due to the overlap with the collagen peaks of the tissue. Notably, 
no proportional relation between VS83 concentration and peak intensities was found. 
While CPA peaks in tissues preserved in pure VS83 correlated to the peak intensities of 
tissues preserved in 25% VS83, tissues preserved in 50% and 75% VS83 showed much 
higher CPA peak intensities (Marzi et al., Appendix III, Figure 3B). It was concluded 
that the cryopreservative effect of the CPAs caused this phenomenon. Highly concen-
trated CPAs eliminated the interstitial water in the cryopreserved tissue, which avoids 
ice-crystal formation and destruction of the tissues. However, this does not result in a 
complete replacement of water by CPAs but the dehydration of the tissue, demonstrated 
in shrunk leaflets with condensed ECM structures (Biermann and Marzi et al., Appendix 
I). In high concentrations and the absence of water, all CPAs seem to rather undergo 
self-association 184-187 than binding to proteins or other tissue structures. Intermolecular 
interactions might dominate in comparison to interactions with the tissue and formation 
of big complexes reduced the permeability 59. Thus, highly concentrated CPAs did not 
permeate into the tissue in the same amount as if in dilution. Raman imaging of un-
washed leaflets confirmed this hypothesis. Unwashed leaflets did not show interstitial 
CPA concentrations that were as concentrated as in the surrounding VS83 medium 
(Marzi et al., Appendix III, Figure 4). Less concentrated CPAs only provide negligible 
self-associating effects and are not capable to push out all of the interstitial water. In this 
case, tissues do not condense, water stays within the tissue and enables a deeper pen-
etration of the CPAs into the tissue, resulting in the detection of higher concentrations 
within the tissue. A better understanding of the cryopreservative effect of VS83 was pro-
vided. Additionally, the necessity for highly concentrated CPAs, that enabled elimination 
of water but at the same time caused less toxic interstitial CPA concentrations, was 
demonstrated.
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5 Results III: Identification and Discrimination of Vascular 
and Non-vascular SMCs and their Phenotypes 
 
Susceptibility of current applied synthetic as well as autologous grafts to throm-
bosis, pseudoaneurysms and infections 188 requires the development of new materials 
for the replacement of vessels. TEVGs derived from decellularized materials, biode-
gradable scaffolds or engineered cell-sheets are the major approaches in cardiovascular 
tissue-engineering 78, 189-191. Biomaterial design itself has strongly evolved, the remaining 
problem is cell source and the control and characterization of cells applied in vascular 
graft constructs. SMCs represent a very heterogeneous group and easily transform be-
tween the two major phenotypes – contractile and synthetic SMC. Maintenance of the 
functional, contractile SMC phenotype is required in both isolated donor vessel SMCs 
as well as stem cell derived SMCs when aiming for a functional persisting graft. Regu-
lation and mechanisms of phenotypic switching are well described 75, 76, however to 
transfer and control phenotypic switching in TE remains difficult 77. The following study 
aimed to established Raman microspectroscopy as quality assessment tool in cardio-
vascular TE. Control and understanding of SMC development and characteristics are 
essential to develop tissue-engineered biomaterials based on nature’s blueprint. Thus, 
the work included the characterization and discrimination of native smooth muscle tis-
sues and cells as well as the monitoring of phenotypic switching in cultured SMCs and 
the assessment of ECM remodeling in tissue-engineered SMC constructs. 
 
5.1 Raman Imaging of Vascular and Non-vascular Smooth Muscle Tissues 
SMCs are present in tissues of vascular but also non-vascular origin. Aorta, ar-
teries, uterus or trachea differ in their anatomic appearance and function. Embedded 
and fixed tissue sections of human aorta, pulmonary artery, uterus and trachea were 
analyzed to define characteristic Raman fingerprints for smooth muscle tissues and to 
localize distinct tissue structures. Raman mapping was performed on defined areas in 
tissue sections. TCA of the spectral data provided intensity heat maps, indicating all 
pixels with similar spectral information and their localization in the sample. The molecu-
lar information of the identified structures could be analyzed by the average spectra of 
the components.  
 
 
5 Results III: Identification and Discrimination of Vascular and Non-Vascular SMCs 
 
 44 
 
Figure 9. Raman imaging of human aortic tissue. (A-D) Main spectral components were extracted. 
Component 1 (A) showed specific peaks for elastin. Component 2 (B) was assigned to collagens. Com-
ponent 3 (C) described cells and nucleic acids and component 4 (D) identified red blood cells. The locali-
zation of these components within the aortic tissue was displayed in intensity heat maps. Scale bar equals 
20 µm. 
 
For the imaging of the smooth muscle tissues, four main components were se-
lected according to the map of the aortic tissue sample (Figure 9 A-D). Component 1 
(Figure 9 A) had a spectral signature for elastin. Peaks distinguishing elastin from colla-
gen were found at 526 and 966 cm-1 correlating to desmosine/isodesmosine. Spectral 
assignment of component 2 (Figure 9 B), with characteristic peaks at 854, 935 and 1245 
cm-1 correlated to hydroxyproline and the C-C backbone in collagen. Component 3 (Fig-
ure 9 C) showed peaks at 782, 1180 and 1340 cm-1 indicating nucleic acids and the 
presence of cells. Component 4 (Figure 9 D), which was only present in some tissues, 
visualized red blood cells with characteristic bands at 750, 1122 and 1593 cm-1, as-
signed to porphyrin and the quinoid ring. The peak at 1001 cm-1 was present in all sam-
ples and is assigned to the highly Raman active C-C ring breathing of the amino acid 
phenylalanine 192, which is present in numerous biological samples. A detailed summary 
of all characteristic peaks and their molecular assignments is provided in supplementary 
table I (Appendix V).  
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These components were applied as reference spectra for the TCA of the other 
samples to compare different smooth muscle tissues. Intensity heat maps of these com-
ponents showed the localization and distribution of the molecules within the uterine tis-
sue, trachea and pulmonary artery (Figure 10). Merging of all components was shown 
in an overlay image for each tissue. Each of the investigated smooth muscle tissues 
showed the presence of all components, but a different distribution of the ECM struc-
tures. Vascular smooth muscle tissues had less collagen and more elastin than non-
vascular tissues. 
 
 
Figure 10. Intensity heatmaps and overlay images of the TCA analysis. The aortic tissue components 
served as reference. The overlay images show the red blood cell (RBC) component in red, the collagen 
component in green, cells in blue and elastin in yellow. 
 
  
overlayeIastincollagenscellsRBC
tra
ch
ea
ut
er
us
pu
lm
on
ar
y
ar
te
y
ao
rta
5 Results III: Identification and Discrimination of Vascular and Non-Vascular SMCs 
 
 46 
In comparison to Raman imaging, routine histochemical analyses on ECM tissue 
structures were performed. Movat-Pentachrome staining (Figure 11 A-D) identified nu-
clei and elastic fibers (black), collagen fibers (yellow), ground substance and mucin 
(blue), muscle (red) and fibrin (bright red). SHG allowed for a label-free imaging of the 
collagen structures, which were detectable in all vascular tissues (Figure 11 E-H). In 
non-vascular tissues, collagen structures, ground substance and muscle tissue were 
dominating. In the bright field mode of the Raman microscope, collagen bundles were 
visible and targeted for single spectrum acquisition (Figure 11 I-L).  
 
Figure 11. Routine histochemical analyses. Performed on aorta (A, E, I), pulmonary artery (B, F, J), 
uterus (C, G, K) and trachea (D, H, L) smooth muscle tissue sections. (A-D), Movat-Pentachrome staining 
identified nuclei, elastic fibers (black), collagen fibers (yellow), glycosaminoglycans, mucin (blue), muscle 
(red) and fibrin (bright red). Scale bar equals 100 µm. (E-H) SHG imaging showed collagen structures 
(green). Scale bar equals 100 µm. (I-L) Contrast phase bright field Raman microscope images allowed 
for targeting larger collagen bundle structures for single Raman spectra acquisition. Scale bar equals 20 
µm. 
For detailed analysis, a PCA was performed on single spectra randomly acquired 
of the collagen structures of each tissue. The PC2/PC3 scores plot allowed for a sepa-
ration of the investigated smooth muscle tissues. A separation of vascular and non-vas-
cular tissues was found in PC2 based on collagen content. Aortic and pulmonary artery 
data as well as uterine and trachea data were separated due to spectral differences in 
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PC3, referring to differences in the architectural structure of collagen (Marzi et al., Ap-
pendix IV, Figure 7). 
These results confirmed the different collagen quantities in smooth muscle tis-
sues shown as well in Raman imaging, multiphoton imaging and Movat-Pentachrome 
staining (Figure 11). All methods identified high collagen contents in uterus and trachea 
tissue, followed by collagens in the aorta. Pulmonary artery tissue did not show much 
collagen. Raman microspectroscopy provided spectral maps with information on a mo-
lecular level and allowed to marker-independently image different structures. Routine 
immunostaining and histochemical analyses showed tissue structures and cellular com-
ponents, but staining was time-consuming and only allowed assessment of a limited 
number of tissue structures for each staining method. Other label-free techniques such 
as multiphoton laser-induced SHG imaging were only applicable for the detection of col-
lagen structures. 
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5.2 Raman Imaging of Vascular and Non-vascular SMCs 
Smooth muscle tissues could be separated according to their Raman fingerprint. 
Clustering was mainly explained by differences in ECM structures, especially to colla-
gen fibers. To further investigate differences in tissue origin on a cellular level, we 
aimed to analyze isolated human SMCs of different smooth muscle tissue origins. Hu-
man vascular SMCs isolated from aorta (HAoSMCs), pulmonary artery (HPASMCs) 
and coronary artery (HCASMCs), and non-vascular SMCs originating from uterus 
(HUtSMCs) and trachea (HTSMCs) were analyzed in vitro. Cells of passage 6 were 
cultured for 48 h, fixed in 4% paraformaldehyde and imaged. For the imaging of single 
SMCs of different tissue origins, four main components were selected in the TCA (Fig-
ure 12 A-D). Component 1 (Figure 12 A) described membrane structures and con-
tained spectral information of phospholipids. Characteristic peaks for phospholipid 
bonds such as choline or C-N vibrations were present at 715, 875 and 1080 cm-1. 
Component 2 (Figure 12 B) was related to lipids and lipid droplet peaks, representing 
the golgi apparatus 193. Peaks different from phospholipids were found at 878 and 968 
cm-1. Most of the differences between phospholipids and lipids were peak shifts, but 
not the presence or absence of peaks. Additionally, in comparison to phospholipid bi-
layers, lipid droplets showed a stronger Raman signal in the area around 2800 cm-1 
194. Component 3 (Figure 12 C) displayed proteins and had characteristic peaks at 
1308 and 1660 cm-1 assigned to amide III and amide I. Component 4 (Figure 12 D) 
identified cell nuclei and had peaks at 786, 1251 and 1577 cm-1 correlating to DNA 
phosphate and bases. TCA allowed for the localization of these components in the cell. 
The defined components for HAoSMCs were used as reference spectra for the analy-
sis of the other cell types (Figure 12E). Proteins, nucleic acids, lipids and phospholip-
ids were detectable in HCASMCs, HPASMCs, HTSMC and HUtSMCs and different 
distribution patterns were shown. In the combined images of all components for all dif-
ferent cells the nucleus could clearly be identified but the proportion and localization of 
the other components differed in each SMC type. A detailed summary of all character-
istic peaks and their molecular assignments is shown in supplementary table II (Ap-
pendix VI). 
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Figure 12. Raman imaging of single adherent hSMCs. (A-D) TCA identified four main spectral compo-
nents in HAoSMCs. Component 1 (A) showed specific peaks for phospholipids and membrane. Compo-
nent 2 (B) was assigned to lipids. Component 3 (C) described proteins and component 4 (D) identified 
nucleic acids. (E) HAoSMC components served as reference for TCA of the other cells. The intensity heat 
maps showed phospholipids in pink, the lipid component in blue, proteins in green and the nucleic acids 
component in red.  
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5.3 Discrimination of SMCs of Different Tissue Origins 
Raman imaging of single adherent SMCs allowed for the identification and local-
ization of distinct cellular components such as the nucleus, lipids and proteins. TCA al-
lowed for the separation of the main cellular components. In relation to the overall data 
sets, small spectral differences such as a peak shift or intensity differences indicating 
intramolecular changes were barely detectable by TCA. Raman imaging can be applied 
to visualize the localization of cellular structures within the cell or to monitor physiological 
or triggered effects in real-time. However, for fast characterization of a larger batch of 
cells, this technique would be too time-consuming. The acquisition of an image of a 
single cell with a pixel size of 1x1 µm took about an hour. To develop a fast protocol with 
the further option and accessibility for cell sorting, single spectra acquisition of cells in 
suspension were performed. PCA was applied to check for spectral differences between 
the SMCs of different tissue origins. PC2/PC3 scores plot indicated a separation be-
tween the five different groups of SMC tissue origin (Marzi et al., Appendix IV, Figure 
2). Each group demonstrated a specific Raman fingerprint. PC2 explained a separation 
within the SMCs of the vascular and non-vascular group. PC3 separated SMCs of non-
vascular and vascular origin. The loadings plot of PC 2 described information related to 
the cell nuclei. Differences within vascular and non-vascular SMCs were determined by 
peaks assigned to DNA (720 cm-1), nucleic bases (778 and 1294 cm-1) and the phos-
phate backbone of the DNA (1090 and 1434 cm-1). A separation of non-vascular and 
vascular SMCs according to PC 3 was depending on cellular structures. Peaks de-
scribed by the loadings plot of PC3 correlated to lipids (1125 and 1339 cm-1), proteins 
(1250 and 1650 cm-1) and phosphatidylinositol (775 cm-1) (Marzi et al, Appendix IV). 
An additional PCA to elaborate smaller differences within the vascular group was 
conducted. Analysis of vascular SMCs (Figure 13) showed a clustering of all groups, 
however only HCASCMs differed significantly from the other cells in PC2 and HPASMCs 
in PC3. Spectral data from HAoSMC partly overlapped with HPASMC data in PC2 and 
with HCASMC data in PC3. PC2 explained a separation based on peaks at 788, 877 
and 1438 cm-1, referring to DNA, the C-N-N symmetric stretching in lipids and CH2-CH3 
deformation vibrations in proteins. Peaks in PC3 loadings plot were found at 936, 1341 
and 1447 cm-1 that correlated to the C-C backbone in proteins, the DNA bases adenine 
and guanine and CH2 deformation in proteins.  
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Figure 13. PCA of vascular SMCs. Detailed analysis of vascular SMCs showed a significant clustering 
of coronary smooth muscle cells (HCASMCs) in PC2 and a separation of pulmonary smooth muscle cells 
(HPASMCs) in PC3. n=30; *p<0.05, ***p<0.001 
Moreover, standard techniques for protein and gene expression analysis were 
applied on passage 6 cells of all tissue origins. Immunocytochemistry (ICC) on smooth 
muscle myosin heavy chain 11 (MYH11) and calponin (CNN1) as well as quantitative 
polymerase chain reaction (qPCR) were performed. RNA expression of alpha smooth 
muscle actin (a-SMA, ACTA2), CNN1, caldesmon (CALD1), MYH11 and collagen I 
(COL1A1) and collagen III (COL3A1) were analyzed by qPCR. MYH11, CNN1, ACTA2 
and CALD1 are proteins of the contractile apparatus and are reported to be specifically 
expressed in SMCs of the contractile phenotype 75, 195. Col I and III were analyzed to 
assess ECM deposition and switching to the synthetic phenotype. Contractile marker 
expression did not differ significantly between all SMCs (Marzi et al., Appendix IV, Fig-
ure 3A-F). The results did not allow for the definition of a specific gene expression pat-
tern that would distinguish and identify the SMCs of the different tissue origins as shown 
by PCA. Furthermore, significantly different gene expression levels were not detected in 
vascular and non-vascular SMCs. In ICC, all SMCs expressed MYH11 and CNN1, how-
ever there was no significant difference in protein deposition patterns that could help to 
discriminate HAoSMCs, HCASMCs, HPASMCs, HTSMCs and HUtSMCs (Marzi et al., 
Appendix IV, Figure 3G). 
This work showed that SMCs of vascular and non-vascular tissues differ in their 
molecular composition. Moreover, also within the group of vascular SMCs a separation 
was indicated by PCA. Although SMCs are highly diverse in their phenotype, differences 
between SMCs of distinct tissue origin were shown in a clear separation in the PCA, 
indicating that spectral differences due to SMC heterogeneity are less influencing within 
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the same passage than inter-populational differences of SMCs of different tissues. For 
in-depth analysis of SMC heterogeneity and phenotype variability within one population, 
Raman analysis of more than 30 cells might be needed to have a representative number 
of phenotype intermediates.  
The biochemical Raman fingerprint of the cells of all different SMC origins varied. 
Monitoring and identification of SMCs isolated from different tissue origins has not been 
thoroughly investigated. Most studies focused on the distinction of contractile and syn-
thetic SMC phenotype within the same tissue 196, 197. Gabbiani et al analyzed different 
vascular SMCs and non-vascular SMCs in various mammals by gel electrophoresis and 
immunofluorescence microscopy 198. Intermediate-size filaments were examined. Vi-
mentin and aSMA were reported to be dominantly expressed in vascular SMCs, 
whereas in non-vascular SMCs the major filament was desmin and gSMA was mostly 
expressed instead of aSMA 198. 
These features make Raman microspectroscopy and Raman imaging into a val-
uable tool to characterize and identify SMCs as it has already been shown before for 
other cell types such as stem cells 121, 122. Hereby we showed a technique superior to 
marker-based routine techniques that did not enable a discrimination of SMCs of differ-
ent tissue origins. 
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5.4 Discrimination of SMC Phenotypic Switching 
SMCs represent a very heterogeneous cell population within one tissue. Whereas 
cellular differences between different smooth muscle tissues have not been investigated 
before, phenotypic changes in one SMC population are well described 75. Functional 
SMCs usually express characteristics of the contractile phenotype. Phenotypic switching 
to the synthetic phenotype was often reported in relation to development and diseases 
such as atherosclerosis or aneurysms 199-201. Moreover, many physiological and external 
triggers inducing phenotypic switching have been described 195, 202-204. Several genes 
and proteins are dominantly expressed in either the contractile or synthetic phenotype 
75, 195, 204. However, it is hard to define a single marker gene or protein identifying a SMC 
as clearly contractile or synthetic phenotype. Most of these markers are also transiently 
expressed in the other phenotype as well as in other cell types, another difficulty is the 
presence of intermediate states of the phenotypes 75. 
This work aimed to apply Raman microspectroscopy to monitor changes in pri-
mary isolated SMCs in culture. Therefore, SMCs of a vascular (coronary artery) and a 
non-vascular (uterus) origin were cultured for 20 passages and measured by Raman 
microspectroscopy. Additionally, ICC was performed. PCA indicated a shift in spectral 
information over the period of culture in both populations (Marzi et al., Appendix IV, 
Figure 4C, D). Both SMC types showed a significant difference between low and high 
passages. For HUTSMCs a first phenotypic alteration was detectable after passage 6, 
whereas for HCASMC a significant change of the cell composition was not detected 
before passage 10. SMCs appeared to differ in their phenotypic switching.  
In parallel to Raman measurements, standard ICC was performed (Marzi et al., 
Appendix IV, Figure 5). Morphological alterations throughout culture time were visible 
in bright field images. Low passage HUtSMCs clearly showed the spindle-shaped mor-
phology of contractile SMCs. However, low passage HCASMCs were less differentiated 
in their morphology. HUtSMCs represented a significant shift in morphology to a rhom-
boid, fibroblast-like shape in high passage. HCASMCs also depicted a synthetic pheno-
type in higher passages. Cells of low (4 & 6) and high (20) passage were stained for the 
contractile phenotype marker CNN1 and three other markers related to the synthetic 
phenotype. Connexin 43 (CX43), COL1 and Syndecan-4 (SYN4) are mainly expressed 
in SMCs of the synthetic phenotype 75, 205 and have been reported in relation to pheno-
typic switching in coronary artery SMCs 206, 207, ECM production 208 and aortic aneurysms 
209, 210. ICC for CNN1 showed a decrease of protein expression over passaging in 
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HUtSMCs. Cells of low passages stained positive for CNN1, in passage 20 only few 
cells expressed the contractile marker protein. In HCASMCs no significantly different 
CNN1 expression patterns between high and low passage cells were found. ICC for 
synthetic SMC phenotype proteins was positive in vascular and non-vascular SMCs in 
low and high passage. However, COL1 was stronger expressed in HCASMCs of higher 
passage, indicating a switch to the synthetic SMC phenotype (Marzi et al., Appendix 
IV, Figure 5).  
ICC results complied with the results of the Raman measurements. For both cell 
types cellular alterations were detected over passage time. In addition, it was shown that 
uterine SMCs underwent a more significant phenotypic switch, while HCASMC indicated 
a smooth transition to the synthetic phenotype. Biomolecular changes were unambigu-
ously detectable and definable in the Raman results, whereas in ICC and PCR a clear 
infallible marker was lacking. There exists a large number of markers that are dominantly 
expressed in either the synthetic or contractile SMC phenotype 75. However, this does 
not imply that those markers are not completely missing in the other phenotype and can 
also be expressed in other cell types such as fibroblast or other cardiovascular cells 30, 
154, 211. Standard techniques demonstrated the difficulty to rely on one single marker to 
define the phenotypic state of a SMC. Moreover, transition states exist in between the 
synthetic and contractile phenotype. In contrary, Raman microspectroscopy provided 
the overall biomolecular fingerprint of the cell, containing molecular information describ-
ing the overall composition of single cells and enabling the detection of cellular changes 
and the definition of the time point of differentiation. This might also be of particular in-
terest for stem-cell derived tissue-engineering approaches. 
According to our results, we conclude that SMCs applied for TE should be of 
passage 6 - 7 or below to guarantee the dominance of SMCs of functional, contractile 
phenotype. A comparable study by Timraz et al. investigated the behavior of HAoSMCs 
in culture and reported a similar result 212. Based on the analysis of cell morphology, ICC 
on MYH11, aSMA, COL1 and COL3 and marker gene expression passage 7 was iden-
tified as the intermediate state between contractile and synthetic phenotype.  
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5.5 Analysis of Tissue-Engineered Vascular Rings 
A major obstacle for rapidly evolving TE approaches is to control and monitor the 
development, degeneration and functionality of the biomaterial 213, 214. An additional as-
pect in cell-based approaches is the assessment of cell differentiation states. This is of 
major interest for stem cell-based approaches, which provide the advantage of being 
differentiable to various kinds of cells, however it needs to be guaranteed that they dif-
ferentiate exactly into the required type of cell 72. However, also for smooth muscle cells, 
there exists a broad populational heterogeneity and the risk of phenotypic switching, as 
it was described before 77. Therefore, Raman analyses were applied to compare the 
tissue structure of tissue-engineered SMC rings to native smooth muscle tissue. SMC 
rings are scaffold-free tissue constructs formed in agarose wells by self-assembly of 
primary or stem cell-derived SMCs 71, 215, 216. SMC rings can be assembled to a vascular 
graft tube with the option to incorporate microspheres or microbeads to allow supple-
mentation with drugs or growth factors 83, 217. Moreover, these constructs provide optimal 
features to be applied for ex vivo drug testing and disease modeling. Raman spectro-
scopic measurements were performed on rings formed by primary human vascular 
SMCs in order to non-invasively analyze the tissue structures. First, SMC rings that were 
cultured under different conditions were compared. The influence of quiescence and 
growth medium and TGF-b supplementation on ECM remodeling was investigated. Ra-
man data were acquired from three different groups of rings constructed out of passage 
7 HCASMCs that were cultured for 14 days. The SMC rings were cultured in i) growth 
medium (GM), ii) quiescence medium (QM) or iii) GM supplemented with TGF b 
(GM+TGFb). Raman imaging and TCA identified and localized nuclei as wells as two 
further components (Marzi et al., Appendix IV, Figure 6A). Peaks related to DNA could 
define the nuclei structures, that were detected in one of the TCA components. The 
second component contained peaks referring to contractile proteins 218, 219 and the third 
component identified by TCA, showed peak assignments related to a dissolved and 
dried aggrecan proteoglycan reference (Marzi et al., Appendix IV, Figure 6B) and to 
peaks reported before in proteoglycans and glycosaminoglycans 220. Structures related 
to the Raman signature of contractile proteins showed a strong deposition in QM-cul-
tured rings and a modest deposition in GM-cultured rings. TGFb supplementation to GM 
increased the expression of the contractile proteins, as observed before in SMC culture 
and other cell types 75, 217, 221. The proteoglycan component was distinctively expressed 
in rings in GM culture, TGFb supplementation did not induce a significant alteration in 
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the expression pattern. SMC rings cultured in QM only showed minor proteoglycan dep-
osition. Proteoglycans seemed to play an important role in vascular SMC-derived ECM 
expression. These findings were confirmed by the results of previous studies that re-
ported higher expression of lipoprotein-binding proteoglycans in proliferative vascular 
SMCs compared to quiescent SMCs 222 and the relevance of proteoglycans (hyaluronan 
and versican) for vascular SMC migration and proliferation 223. Suna et al described the 
impact of aggrecan in ECM remodeling in vasculature and reported aggrecan gene ex-
pression specifically in vascular SMCs, whereas vascular endothelial cells lacked ag-
grecan expressing genes 224. Moreover, extensive aggrecan and versican deposition 
have been reported in aortic aneurysm tissue 225. 
A PCA was performed on single point measurements of the rings structures for 
detailed analysis of spectral differences and to search for specific Raman fingerprints, 
identifying the SMC rings of QM, GM and GM+TGF culture conditions. A distinct clus-
tering for each culture condition was demonstrated (Marzi et al., Appendix IV, Figure 
6C). While PC3 allowed for a significant separation between each group, PC 5 allowed 
for a separation of the rings cultured in QM from the rings cultured in GM (Marzi et al., 
Appendix IV, Figure 6D). PC3 indicated differences in amino acids and amides in pro-
teins. PC5 explained alterations in collagen. In addition, PC3 and PC5 both showed a 
proteoglycan specific peak at 1008 cm-1 in the positive range of their loadings plots. GM 
and GM+TGF data were mainly described by positive PC3 values and GM data as well 
by positive PC5 data, indicating higher proteoglycan levels in tissue samples of those 
culture conditions (Marzi et al., Appendix IV, Figure 6E). PCA results of ECM protein 
expression in the differently cultured rings correlated to the Raman imaging data. Raman 
imaging and single spectrum acquisition results lead to the conclusion that GM induced 
an increased matrix production, while QM helped to maintain the SMCs contractile phe-
notype with little ECM remodeling and proteoglycan expression. Combination of GM and 
TGFb supported both, a stable matrix and synthesis of functional, contractile proteins. 
These culture conditions were found to be ideal to form a tissue ring that develops intact 
ECM structures which are necessary to sustain the physiological demands of a native 
vessel. Tissue-engineered rings grown in medium with TGFb supplementation or incor-
porated with gelatin beads containing TGFb have already been shown to comply with 
the biomechanical properties of native tissue 217. 
In addition, tissue rings formed by HAoSMCs were compared to native aortic tis-
sue to identify molecular and structural differences or similarities between native tissue 
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and the tissue-engineering approach. While smooth muscle tissues of different anatom-
ical origins differed in their Raman information no significant difference was detectable 
between HAoSMC rings and aortic tissue. Except for PC1 that indicated a difference in 
the baseline of the Raman spectra, similarities in the spectral assignment of native aorta 
and tissue-engineered HAoSMC rings were described by the PCA (Marzi et al., Appen-
dix IV, Figure 8G). The tissue-engineered constructs resembled the molecular Raman 
fingerprint of the corresponding native aortic tissue, leading to the conclusion that the 
applied protocol to form and culture SMC rings led to a tissue-engineered graft with 
matrix structures comparable to those of native human aorta. In addition to the success-
ful characterization of the tissue-engineered SMC rings, the results demonstrated the 
potential of Raman imaging and microspectroscopy as quality control tool in TE.
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6 General Discussion & Outlook 
 
6.1 Quality Assessment in Cardiovascular Cells and Tissues 
Raman microspectroscopy combined with MVA was established for diverse ap-
plications in the analysis of cardiovascular implant materials. The assessment of ECM 
changes on a molecular level, the discrimination of SMCs of different tissue origin and 
phenotype, the monitoring of ECM remodeling in tissue-engineered vascular SMC rings 
as well as successful interstitial quantification of cytotoxic chemicals were demonstrated. 
Raman analysis provided relevant additional information compared to standard tech-
niques and is an easy, accessible technique for diverse sample conditions. Little sample 
preparation and no destructive labeling is required.  
Compared to previous preclinical and mid-term studies on cryopreserved heart 
valve leaflets 15, 50, 55 that only applied multiphoton imaging and standard histochemistry 
techniques, Raman microspectroscopy provided additional input on the character of the 
cryopreservation-induced structural ECM damages, which was not previously accessi-
ble. It was shown that FC-induced deterioration, but no degradation of the collagen fibers 
in ovine pulmonary leaflets. In contrary, collagen degradation was reported in FC porcine 
tissues. Raman measurements of ovine and porcine control tissues led to the hypothesis 
that ovine and porcine tissues show minor alterations in their ECM composition that 
cause a different sensitivity to cryopreservation. Whereas for the assessment of SMCs 
several cellular and tissue components were compared, the heart valve study mainly 
focused on collagen structures. However, Raman microspectroscopy has also been 
shown to assess lipids, proteins and GAGs as demonstrated in a study that quantified 
the influence of two different decellularization procedures on aortic implants 226. Moreo-
ver, Raman spectroscopy was not only applicable to non-invasively monitor and quantify 
CPAs in supernatants and tissues, which so far was only demonstrated by NIR spec-
troscopy 183, but supported the evaluation of the underlying mechanism of CPA action.  
Many attempts in heart valve and vascular TE failed in preclinics or clinics 17, 68. 
There is an urgent need in cardiovascular tissue-engineering to assess detailed preclin-
ical information. The results of this study showed the sensitivity of Raman techniques to 
detect mechanically and immunologically induced structural ECM changes. Moreover, 
another study reported a Raman signature for the prediction of cardiac allograft rejection 
227. In addition to the analysis of allografts and xenografts, as performed in this work, 
6 Discussion & Outlook 
 
 62 
Raman microspectroscopy and imaging would be of further interest for the quality as-
sessment in evolving field of tissue-engineered heart valves. The comparison of newly 
formed tissue structures within native tissues or the characterization of implanted bio-
materials itself, but also the monitoring of the degradation of the biomaterials and cell-
biomaterial interactions are promising future applications. Furthermore, this approach 
could equally be applied for the real-time monitoring of tissue-engineered heart valves 
or vascular grafts in bioreactors as it has been applied for cell culture before 228. In ad-
dition to the potential application in bioreactors, Raman spectroscopy provides the ideal 
properties for non-invasive monitoring in microfluidic systems. Microfluidic systems, so-
called organ-on-a-chip models, recapitulate the microstructure and function of living or-
gans and would allow for animal-free drug testing. Cardiovascular organ-on-a-chip ap-
proaches such as ‘heart-on-a-chip’ or setups with iPSC-derived cardiomyocytes 229, 230 
would benefit from a marker-free in situ monitoring tool as it could be shown for the 
assessment of glucose stimulation in a pancreas-on-a-chip model (Zbinden, Marzi et al., 
in preparation). 
However, prior to pre-implant control and in situ monitoring of tissue-engineered 
grafts it is of major importance to characterize and identify the applied cells, especially 
if stem cell-derived cells are utilized. An enhanced molecular understanding of SMC 
biology could facilitate the design of more potent cell-based biomaterials and regulate 
SMC differentiation behavior in vascular TE 77. SMC analysis was based on the acquisi-
tion of one specific Raman fingerprint per cell defining the overall cellular composition 
and enabling fast identification and discrimination by PCA. According to the Raman fin-
gerprint it was possible to distinguish phenotypic switching in SMCs, which is a widely 
investigated phenomenon in SMCs 75, 202, 204, but has never been reported to be as-
sessed non-destructively and label-free. Moreover, a marker-independent separation of 
SMCs of different smooth muscle tissue origins was demonstrated. A significant differ-
ence was shown between vascular and non-vascular SMCs, but also SMCs of aorta, 
coronary artery and pulmonary artery showed differences in their overall cellular com-
position. Inter-populational differences between different tissue origins had a higher rel-
evance than intra-populational heterogeneity within one passage of SMCs. In contrary 
to the conclusion by Huber et al. 231 who stated that SMC origin plays a negligible role 
in TE, the results indicated a relevance for the selection of passage as well as SMC 
origin for tissue-engineering approaches. Previously, only few studies compared SMCs 
of different origins and except for one study by Gabbiani et al only vascular and non-
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vascular cells were compared 198. For detailed mechanistic investigations and the spe-
cific assessment of defined cellular proteins, Raman instrumentation and data analysis 
might still need further development and are not superior to the selectivity of established 
techniques such as immunofluorescence labeling or gene expression analysis. It is es-
sential to harmonize and normalize Raman applications for a successful introduction in 
standardized cell culture screening or Raman activated cell sorting (RACS) 232, 233 or 
clinical applications. Nevertheless, these results are a promising indicator towards es-
tablishing Raman microspectroscopy as non-destructive quality control tool in cell-based 
TE approaches for real-time monitoring of the material formation as well as for the pre-
selection and characterization of the applied cells. 
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6.2 Data Assessment in Multiphoton Microscopy and Raman Microspectros-
copy 
 
Similar to Raman microspectroscopy, multiphoton imaging can be applied label-
free, is non-invasive and does not require complex sample preparation. In contrast, it is 
only accessible to a limited number of endogenous fluorescent or SHG-active molecules, 
otherwise it has to be applied in combination with immunofluorescent dyes 234. Due to 
the rare event of Raman scattering in only 1 of 107, multiphoton imaging is more efficient 
and requires shorter acquisition times than spontaneous Raman scattering imaging. 
Multiphoton images allowed for the fast assessment of qualitative characteristics of col-
lagen and elastic fibers, such as localization, distribution and appearance of fiber struc-
tures. In addition, it has been shown that also paraffin-embedded and fixed smooth mus-
cle tissues provided multiphoton collagen signals, as demonstrated before for fixed skin 
and heart valve tissue 235. This study showed that multiphoton microscopy is well-suited 
for fast, non-invasive assessment of the influence of biomechanical stress on heart valve 
leaflet ECM structures as it has been reported previously for coronary artery microstruc-
ture 236. However, more detailed analysis is not possible in multiphoton microscopy. In 
particular, deterioration in FC leaflet collagen structures were visualized and could be 
qualified according to crimp structure properties, but detailed information on molecular 
changes induced by the cryopreservation method were only accessible by Raman mi-
crospectroscopic measurements. Moreover, in multiphoton imaging no differences were 
detected between allogeneic and xenogeneic ECM structures, except for the infiltrating 
cells, whereas Raman microspectroscopy revealed inflammation-dependent structural 
differences. The same outcome applied accordingly for collagen detection in smooth 
muscle tissues. A determination of collagen quantities in different smooth muscle tissues 
was possible. However, no further differences could be defined by qualitative multipho-
ton imaging. Quantitative multiphoton approaches combined with MVA or the calculation 
of signal ratios and the combination of SHG and TPEF imaging 237 might allow for a more 
detailed data output. A further approach would be fluorescence lifetime imaging (FLIM). 
FLIM is based quantification and has recently been reported to allow for the determina-
tion of collagen/elastin ratios in vascular grafts and biochemical imaging of coronary 
arteries and atherosclerotic plaques 238-241. 
While Raman imaging assesses the molecular information by acquiring a broad-
band spectrum in every single pixel and therefore requires more time to achieve a res-
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olution enabling imaging of defined structures, multiphoton imaging allowed for fast la-
bel-free imaging of defined structures, comparable to coherent anti-Stokes Raman scat-
tering microscopy (CARS) at a defined Raman shift wavenumber. In the future, multi-
modal imaging with a combination of multiphoton microscopy and Raman microspec-
troscopy would represent an advanced analysis tool for cardiovascular ECM structures. 
Recent studies already reported the combination of Raman and multiphoton imaging in 
investigations on skin and liver tissue 242, 243 and as pathological tool for the detection of 
skin melanoma 244.  
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6.3 Standard Techniques and Raman Spectroscopy for Characterization of 
ECM Structures and Cells 
 
A major challenge in characterization of biomaterial or replacement tissue is the 
quantification of the properties compared to physiological or biomechanical properties 
of the native tissue 87. The establishment of in vitro test systems that can access infor-
mation on cell-biomaterial interaction, cellular processes and biocompatibility is still 
evolving regarding relevance to in vivo testing, cost-efficiency and reliability 245. The re-
sults of this thesis showed that Raman microscopy and imaging could provide many of 
the required features for quality assessment in cardiovascular research that are still 
missing in standard techniques such as immunofluorescence microscopy, standard his-
tochemistry or gene and protein expression assays. 
Raman spectroscopy is highly precise and detects differences in molecular com-
position of ECM structures. Standard histochemical staining performed on smooth mus-
cle tissues and in the heart valve long-term study was time-consuming, could not be 
performed on fresh tissues and only confirmed the results of previous studies 50, 55. How-
ever, Raman microspectroscopy and MVA as well as the analysis of crimp structures by 
multiphoton imaging, provided quantitative as well as qualitative input on the remodeling 
and degeneration of FC heart valve leaflets on a molecular level that have not been 
shown before by any other method. Furthermore, PCA allowed for a fast classification 
of the state of ECM integrity in cryopreserved heart valve tissues or of the ECM compo-
sition in smooth muscle tissues. Schenke-Layland et al. applied Movat-Pentachrome 
staining, immunofluorescence labeling and multiphoton microscopy in a study compar-
ing decellularized tissue-engineered heart valve leaflets with native ovine aortic and por-
cine pulmonary leaflets 154. They demonstrated comparable ECM structures in tissue-
engineered and native tissues and no remarkable difference between the two native 
tissues. In comparison, this study showed that Raman spectroscopy could identify minor 
structural differences in native ovine and porcine pulmonary leaflets that might be rele-
vant for the different response of porcine and ovine tissues to the IFC and FC cryopres-
ervation procedures. 
Characterization and in situ monitoring of tissue growth in cell culture is also one 
of the issues in TE where no completely satisfying method has been developed so far 
245. Thus, Raman imaging and PCA demonstrated fast, non-invasive monitoring and 
characterization of ECM remodeling in tissue-engineered SMC rings of different culture 
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conditions and could confirm a similar matrix composition in the tissue-engineered con-
structs and native vessels without processing or destructing them. 
Current methods for the assessment of cell function and gene expression like 
ELISA, ICC or PCR, are time consuming, destructive and inefficient 246. The acquisition 
of the Raman fingerprint of SMCs was more efficient than ICC and qPCR on known 
phenotype markers. PCA demonstrated a significant discrimination of SMCs of different 
tissue origins, helped to monitor phenotypic switching and could be performed in situ. 
Furthermore, Raman Spectroscopy has been shown to be one of the few techniques 
that enabled the monitoring of cell cycle, differentiation, mineralization or metabolism in 
real time and without destructing the cells 247-249. There exist several other imaging tech-
niques, mainly applied in medical imaging, that are non-invasive and allow for 3D recon-
struction of tissue structures 250-252. However, optical coherence tomography, micro x-
ray, computer tomography or magnetic resonance imaging are limited in their resolution 
and molecular sensitivity. Superior characteristics and analytical possibilities shown in 
this thesis, enable the application of Raman spectroscopy in cardiovascular bioprocess 
monitoring and quality control, which are important for end product design 87. 
Nevertheless, spontaneous Raman scattering provides a relatively weak signal 
89. Especially low scattering molecules, such as biomolecules in a tissue environment, 
result in longer acquisition times and high laser powers than isolated molecules or mol-
ecules with high scattering vibrational states 253. Therefore, principles to enhance the 
Raman scattering and reduce interferences were established. CARS is based on the 
stimulation of an anti-Stokes Raman scattering induced by two lasers of the same fre-
quency. A strong, enhanced signal is generated, if the merged frequencies of the two 
lasers correspond to the frequency of the vibration of the Raman active molecule 254-256. 
In general, this approach only considers the assessment of a defined spectral band-
width, such as the CH-/OH- stretch region between 2700-3000 cm-1 257, however new 
multiplex, broadband CARS systems have been developed 258, 259. Another technology 
to access strong Raman spectra is surface-enhanced Raman spectroscopy (SERS). 
SERS provides up to 1011 fold increased signal intensities by signal-enhancing 
nanostructured surfaces 260, 261, first described for silver electrodes 262. An adaption of 
SERS is tip-enhanced Raman spectroscopy, applying a metallic tip similar to the princi-
ple of atomic force microscopy 263. Additionally, structures can be tagged with nanopar-
ticles or CNTs that provide stronger Raman signals 264, 265. In previous work, stimulated 
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Raman or CARS were applied to image SMCs 266, 267. The peak near 2845 cm-1 is es-
pecially sensitive for lipids and often applied to image tissues or cells based on the in-
trinsic lipid contrast. These studies identified SMCs in a tissue or scaffold environment, 
but no detailed SMC subcellular structures were analyzed. Although CARS and SERS 
provide increased Raman signals, they are more complex in technical setup, sample 
preparation, and broadband application. Thus, the work included in this thesis predomi-
nantly focused on spontaneous Raman scattering techniques. 
CARS and SERS provide advantages in sensitivity and acquisition time and 
should be considered in future approaches for analysis of cardiovascular cells and tis-
sues. CARS might play an important role in real-time quality assessment. Once charac-
teristic Raman shift ranges for a SMC phenotype or ECM deterioration are defined, 
CARS could be applied in the defined area for fast, routine imaging and discrimination 
in cardiovascular quality control. SERS enables enhanced signal intensities and higher 
spatial resolution and thus is relevant for the acquisition of singular structures in hetero-
geneously composed tissues or cells, described before in cancer tissues as immuno-
SERS microscopy that can be performed on native tissues or Raman-actively labeled 
antigens 268, 269. Another method of tracking is the application of CNT labeling. This 
method could be utilized to track cell metabolism or tissue-engineered grafts after im-
plantation and can also be applied in in vivo approaches 131, 270. 
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6.4 Biochemical Raman Fingerprint and Reference Spectra 
 The Raman spectral fingerprint presents an overview of a sample and is not nec-
essarily linked to only one defined structure, if not measuring an isolated substance but 
a cell or tissue. Due to the heterogeneously distributed structures in tissues and cells 
and the spatial resolution of about 1 µm in diameter, a Raman spectrum can be assigned 
to several structures such as proteins or lipids. 
Single point measurement spectra and information defined by PCA can be eval-
uated according to reported peaks found in literature. Whereas there exist precise data 
bases of detailed molecular vibrations in small molecules 271, there is limited availability 
of reliable reference databases in biological molecules. There exist reviews that sum-
marize peaks found in different studies on biological tissues and cells 272 and De Gelder 
et al measured various reference spectra of cellular molecules such as DNA, defined 
amino acids, fatty acids and saccharides and metabolites 273. Single point measure-
ments can aim for the analysis of a defined structure, but in quality assessment applica-
tions the overall fingerprint that provides a characteristic assignment for every cell or 
tissue structure is of major interest. The fingerprint does not define a single isolated 
molecule, but represents the general composition of the target and enables fast discrim-
ination of different samples, as it was shown in this work for different SMCs.  
However, in image analysis, due to the large number of different spectra, refer-
ence spectra can be beneficial to identify and localize certain structures within the matrix 
of many different assignments. The limiting factor in reference spectrum acquisition is 
not only the extreme diversity of cellular and extracellular molecules, but also the sensi-
tivity of Raman microspectroscopy to structural alterations 274, 275. An isolated, lyophi-
lized commercially available protein can have another structural constitution than the 
same protein in a tissue, resulting in minor spectral differences 127. Thus, the measure-
ment of lyophilized, isolated molecules as reference standard might not be precise 
enough because Raman spectra of biological molecules of a similar structure only differ 
marginally. For example, the Raman spectra of different collagen types (Figure 14), 
measured as lyophilized reference substances, indicated spectral differences mainly in 
different peak ratios, peak intensities or peak shifts and barely in the presence or ab-
sence of a peak. Therefore, there is a need for a systemic evaluation of the variables 
influencing a possible reference substance. The most reliable, however time-consuming, 
option to establish a biomolecule database would be Raman measurements by targeting 
an immunofluorescence-labeled molecule in its native surrounding.  
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Figure 14. Raman spectra of different collagen types.  
Depending on the experimental setup and hypothesis it should be considered 
whether a Raman fingerprint is sufficient or if reference spectra of defined molecules 
have to be obtained for the analysis. Whereas the Raman fingerprint is ideal for the 
characterization of spectral alterations and the separation of data sets or identification 
of a data point, as applied in MVA tools, deeper mechanistic or structural analyses and 
especially Raman image analysis would extremely benefit from a database of defined 
biomolecules. Previous studies reported TCA or Raman data analysis of cardiovascular 
tissues in combination with linear combination of basis spectra 218, 219, 276. However, only 
a limited number of reference spectra was investigated and the acquisition of reference 
spectra was always a precondition of the study. In future work, a major goal should be 
the establishment of an accessible and standardized ECM reference database for car-
diovascular and other tissue ECM characterization which allows for in-depth analysis 
and reliable identification of small molecules. A database would circumvent the analysis 
of unknown components determined by TCA by identification and fitting of defined ref-
erence spectra.  
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6.5 Single Spectrum Acquisition Versus Raman Imaging 
Raman imaging and single point Raman measurements were applied for the anal-
ysis of SMCs and smooth muscle tissues as well as for the quantification of interstitial 
DMSO, PG and FMD concentrations. The choice of the method depended on the scien-
tific question that should be addressed. Single point measurements allowed to preselect 
a defined structure and generate a Raman fingerprint that enables in-depth molecular 
characterization of the structure. However, reliable targeting is only possible if the region 
of interest is a clearly microscopically detectable structure or cell or if the data acquisition 
is combined with immunofluorescence labeling 97. Raman imaging is more time-consum-
ing, but enabled to access all the spectral information within a defined area. Further-
more, low-resolution imaging allows for fast monitoring of the distribution of strong scat-
tering chemicals in weak scattering tissues. Large data sets are created that enable 
various analyses. Simple image generation by filter settings and intensity heat maps 
allow a fast, label-free visualization of higher scattering structures.  
For in-depth analysis and the identification of the major spectral components in 
spectral maps, TCA, PCA or cluster analysis can be applied. In contrary to PCA, com-
ponents defined by TCA depend on the number of selected components and only de-
scribe an approximation of the defined spectral information. Spectra identified in a com-
ponent may vary from the actual spectral assignment to a certain degree. Thus, for some 
SMC types only noisy images could be achieved when employing the spectral compo-
nents defined in HAoSMC as reference spectra in the analysis. Proteins, lipids, mem-
brane lipids and DNA were identified as main components in the aortic SMCs. The nu-
clear component was found in all cells, regardless of tissue origin. However, for the pro-
tein and lipid structures, especially of the non-vascular cells, the reference spectrum of 
hAoSMC did not perfectly fit to image these structures in the other cells. An independent 
analysis showed a better fit to the cellular structures than the fitting with the HAoSMC 
reference spectra (Figure 15). HTSMC and HUtSMC were less noisy in the independent 
TCA (Figure 15 B, D) than in the TCA with the HAoSMC reference spectra (Figure 15 A, 
C). Comparison of the identified spectra with the HAoSMC spectra indicated slight dif-
ferences in the lipid composition in HAoSMCs and HUtSMCs (Figure 15 E) and differ-
ences in protein composition in HAoSMCs, HUtSMC and HTSMCs (Figure 15 F). This 
implied not only a different distribution and quantity of lipids and proteins in the cells, but 
also a different composition of those molecular structures.  
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Figure 15. TCA of HSMCs. Independent TCA (B, D) on HTSMCs (A, B) and HUtSMCs (C, D) revealed 
precise imaging compared to the TCA with the identified spectra for proteins, lipids, phospholipids and 
nuclei in HAoSMCs (A, C). Comparison of the TCA components, described differences in the lipid spec-
trum of HAoSMCs and HUtSMCs (E) and differences in the protein spectrum between HAoSMCs, 
HTSMCs and HUtSMCs (F). 
Moreover, also complex MVA can be performed on preselected, extracted re-
gions of interest defined by TCA to determine minor structural differences within one of 
the structural components in the image. This would be comparable to MVA of single 
point measurements and was shown for the analysis of lipid composition before and 
after glucose stimulation in a pancreas-on-a-chip model (Zbinden, Marzi et al., in prep-
aration) or the characterization of molecular changes in elastic and collagen fibers in the 
aortas of different murine genotypes (Sugiyama, Marzi et al., in preparation). 
The choice regarding whether detailed molecular information of a certain struc-
ture is required or an overview image of a defined area with different structures is of 
major interest should be carefully considered. Single point Raman measurements allow 
for the fast assessment of the Raman fingerprint of a cell or tissue structure that enables 
detailed molecular characterization and would be sufficient information for a possible 
application for cell sorting. In contrary, Raman imaging allows the label-free image gen-
eration of a tissue or cell area and demonstrates the localization and quantitative distri-
bution of several tissue or cell structures simultaneously.  
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6.6 Conclusion 
In situ monitoring and characterization of cellular properties or cell-material inter-
actions represents a major obstacle in the constantly evolving field of TE. This study 
reported the establishment of Raman microspectroscopy and Raman imaging combined 
with MVA tools for the quality assessment of tissues and cells applied in cardiovascular 
TE. It was successfully demonstrated, that Raman microspectroscopy allowed to identify 
cryopreservation-induced ECM changes in heart valve leaflets and to monitor and quan-
tify CPAs in cardiac tissues. Moreover, SMCs of different tissue origins and phenotype 
were discriminated and classified by MVA according to their Raman fingerprint. Similarly, 
the matrix development in dependence of the culture medium could be monitored in 
tissue-engineered vascular SMC grafts by Raman imaging. In comparison to standard 
techniques such as gene and protein expression analyses, major advantages of the Ra-
man techniques were the marker-independence, non-invasiveness and sensitivity on a 
molecular level, which allowed for real-time and in situ characterization and quantifica-
tion. Single point Raman measurements combined with PCA were shown to be the pre-
ferred technique for a fast assessment of a characteristic Raman fingerprint that allows 
to discriminate and identify variable samples or cells and to analyze minor spectral dif-
ferences in detail. Raman imaging enabled the marker-independent and simultaneous 
visualization of distinct cell, tissue or biomaterial structures and should be favored for 
descriptive studies of structural distributions patterns of different molecules. In addition, 
Raman imaging was highly efficient to study permeation kinetics in tissues. The results 
demonstrated the benefits of Raman techniques, that addressed the analytical needs in 
cardiovascular TE. Raman microspectroscopy and imaging are of great potential for fu-
ture applications such as cell-sorting or in situ monitoring of various metabolic or devel-
opmental processes. Furthermore, the results encourage the application of Raman mi-
crospectroscopy as quality control tool for tissue-engineered grafts. Non-destructive dis-
crimination of different cells or tissues by MVA and the Raman fingerprint is already 
advanced. In the future, more effort still needs to be dedicated to the establishment of 
Raman microspectroscopy for the characterization and identification of single molecules 
in complex biological samples. Whereas identification and monitoring of drugs and 
chemicals is well-established and applied in industry, Raman analysis of biomolecules 
lacks a comprehensive, reliable and standardized data base of references, that would 
facilitate the identification of a broader range of specific molecules.
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e Institue of Medical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin
Institute of Health, Berlin, Germany
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Abstract
OBJECTIVES: Allogeneic frozen cryopreserved heart valves (allografts or homografts) are commonly used in clinical practice. A major
obstacle for their application is the limited availability in particular for paediatrics. Allogeneic large animal studies revealed that alternative
ice-free cryopreservation (IFC) results in better matrix preservation and reduced immunogenicity. The objective of this study was to evalu-
ate xenogeneic (porcine) compared with allogeneic (ovine) IFC heart valves in a large animal study.
METHODS: IFC xenografts and allografts were transplanted in 12 juvenile merino sheep for 1–12 weeks. Immunohistochemistry, ex vivo
computed tomography scans and transforming growth factor-b release profiles were analysed to evaluate postimplantation immunopa-
thology. In addition, near-infrared multiphoton imaging and Raman spectroscopy were employed to evaluate matrix integrity of the
leaflets.
RESULTS: Acellular leaflets were observed in both groups 1 week after implantation. Allogeneic leaflets remained acellular throughout
the entire study. In contrast, xenogeneic valves were infiltrated with abundant T-cells and severely thickened over time. No collagen or
elastin changes could be detected in either group using multiphoton imaging. Raman spectroscopy with principal component analysis
focusing on matrix-specific peaks confirmed no significant differences for explanted allografts. However, xenografts demonstrated clear
matrix changes, enabling detection of distinct inflammatory-driven changes but without variations in the level of transforming growth
factor-b.
CONCLUSIONS: Despite short-term success, mid-term failure of xenogeneic IFC grafts due to a T-cell-mediated extracellular matrix-
triggered immune response was shown.
Keywords: Ice-free cryopreservation • Heart valve transplantation • Allograft • Xenograft • T–cell-mediated immune response • Organ
scarcity
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ABSTRACT: Cryomedium toxicity is a major safety concern
when transplanting cryopreserved organs. Therefore, thorough
removal of potentially toxic cryoprotective agents (CPAs) is
required before transplantation. CPAs such as dimethyl-
sulfoxide (DMSO), propylene glycol (PG), and formamide
(FMD), routinely employed in ice-free cryopreservation
(IFC), have advantages in long-term preservation of tissue
structures compared with conventional cryopreservation
employing lower CPA concentrations. This study evaluated
the impact of potential residual CPAs on human cardiac
valves. Raman microspectroscopy and Raman imaging were
established as nondestructive marker-independent techniques
for in situ quantitative assessment of CPA residues in IFC
valve tissues. In detail, IFC valve leaflets and supernatants of the washing solutions were analyzed to determine the washing
efficiency. A calibration model was developed according to the CPA’s characteristic Raman signals to quantify DMSO, PG and
FMD concentrations in the supernatants. Single point Raman measurements were performed on the intact tissues to analyze
penetration properties. In addition, Raman imaging was utilized to visualize potential CPA residues. Our data showed that
washing decreased the CPA concentration in the final washing solution by 99%, and no residues could be detected in the
washed tissues, validating the multistep CPA removal protocol routinely used for IFC valves. Raman analysis of unwashed
tissues showed different permeation characteristics depending on each CPA and their concentration. Our results demonstrate a
great potential of Raman microspectroscopy and Raman imaging as marker-independent in situ tissue quality control tools with
the ability to assess the presence and concentration of different chemical agents or drugs in preimplantation tissues.
Donor organ scarcity and restricted long-term organviability are limiting factors for transplantation medi-
cine.1 Cryopreservation is a critical technology with numerous
applications in cell and tissue banking. Chemical additives, so-
called cryoprotective agents (CPAs), allow for a better post-
thaw recovery of cells and tissues.2 CPAs play a fundamental
role to guide, reduce, or prevent ice crystal formation and
protect the biological structures during preservation. They
determine the post-thaw condition of the graft and
extracellular matrix (ECM) integrity. At the same time, their
metabolic and biophysical effects bear the risk of potentially
damaging the biological system.3− 5 It is a continuing challenge
to balance the application of sufficiently concentrated but
potentially toxic concentrations of CPAs.6
In clinical practice, standard frozen cryopreservation (FC) of
human cardiac valves has been applied for over three decades.
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a b s t r a c t
Smooth muscle cell (SMC) diversity and plasticity are limiting factors in their characterization and appli-
cation in cardiovascular tissue engineering. This work aimed to evaluate the potential of Raman
microspectroscopy and Raman imaging to distinguish SMCs of different tissue origins and phenotypes.
Cultured human SMCs isolated from different vascular and non-vascular tissues as well as fixed human
SMC-containing tissues were analyzed. In addition, Raman spectra and images of tissue-engineered SMC
constructs were acquired. Routine techniques such as qPCR, histochemistry, histological and immunocy-
tological staining were performed for comparative gene and protein expression analysis. We identified
that SMCs of different tissue origins exhibited unique spectral information that allowed a separation of
all groups of origin by multivariate data analysis (MVA). We were further able to non-invasively monitor
phenotypic switching in cultured SMCs and assess the impact of different culture conditions on extracel-
lular matrix remodeling in the tissue-engineered ring constructs. Interestingly, we identified that the
Raman signature of the human SMC-based ring constructs was similar to the one obtained from native
aortic tissue.
We conclude that Raman microspectroscopic methods are promising tools to characterize cells and
define cellular and extracellular matrix components on a molecular level. In this study, in situ measure-
ments were marker-independent, fast, and identified cellular differences that were not detectable by
established routine techniques. Perspectively, Raman microspectroscopy and MVA in combination with
artificial intelligence can be suitable for automated quality monitoring of (stem) cell and cell-based tissue
engineering products.
Statement of Significance
The accessibility of autologous blood vessels for surgery is limited. Tissue engineering (TE) aims to
develop functional vascular replacements; however, no commercially available TE vascular graft
(TEVG) exists to date. One limiting factor is the availability of a well-characterized and safe cell source.
Smooth muscle cells (SMCs) are generally used for TEVGs. To engineer a TEVG, proliferating SMCs of the
synthesizing phenotype are essential, whereas functional, sustainable TEVGs require SMCs of the contrac-
tile phenotype. SMC diversity and plasticity are therefore limiting factors, also for their quality monitor-
ing and application in TE. In this study, Raman microspectroscopy and imaging combined with machine
learning tools allowed the non-destructive, marker-independent characterization of SMCs, smooth mus-
cle tissues and TE SMC-constructs. The spectral information was specific enough to distinguish for the
first time the phenotypic switching in SMCs in real-time, and monitor the impact of culture conditions
on ECM remodeling in the TE SMC-constructs.
! 2019 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Pre-existing vascular diseases, re-operations and the shifting
indication to an elderly population limit the accessibility of suit-
able autologous vessels in about 30% of the patients undergoing
https://doi.org/10.1016/j.actbio.2019.03.026
1742-7061/! 2019 Acta Materialia Inc. Published by Elsevier Ltd.
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coronary artery bypass surgery [1,2]. Vascular tissue engineering
aims to develop functional, persisting vascular replacements. How-
ever, no commercially available tissue-engineered vascular graft
(TEVG) exists to date. Synthetic grafts as well as TEVG approaches
failed due to the development of stenosis or atherosclerosis [3,4].
Smooth muscle cells (SMCs) are used in tissue engineering for con-
struction of vascular grafts or the assembly of other organs [5–7]
and play a crucial role in vascular pathologies, due to their pheno-
typic switching ability [8–10]. SMCs of the contractile type are
spindle-shaped, provide mainly contractile filaments and are less
proliferative. SMCs of the proliferative or synthetic type show a
rhomboid, fibroblast-like shape, dominate in protein synthesizing
organelles and have a higher proliferation rate [11,12]. To populate
and seed a tissue-engineered construct, proliferating SMCs of the
synthesizing phenotype are essential, whereas functional, sustain-
able TEVGs require SMCs of the contractile phenotype. Phenotypic
switching and its stimuli and regulating factors are extensively
described in basic research [13–16] and the relevance for tissue
engineering has been discussed by others [17,18]. Despite detailed
mechanistic studies, most research regarding SMC behavior is
observational and lack an approach to control and direct SMC plas-
ticity in tissue-engineering constructs. Moreover, there are no
methods for the reliable, consistent and quantitative characteriza-
tion of SMC phenotypes in situ, as well as their differentiation
within tissue constructs [17].
SMC tissue origin is another area that needs addressing for
cell-based biomaterial design. Smooth muscle tissue is prevalent
in distinct anatomic body compartments. It is well known that
the vasculature contains a smooth muscle layer; however lesser
known tissues such as the urinary, uterine and gastrointestinal
tracts are composed of smooth muscle tissue as well. Although
these tissues differ in their function and appearance, all of them
are formed by SMCs. To date very little is known regarding the
tissue-specific characteristics of primary SMCs. Very few studies
have compared SMCs of different tissue origin [19,20]. Quantitative
distinction between SMCs of distinct anatomical regions and the
impact of the selected tissue origin of SMCs applied for tissue engi-
neering have not been thoroughly investigated.
In the present study, we employed a technique that enables
marker-independent, non-destructive in situ microscopy that pro-
vides molecular information of cell and tissue samples. Raman
microspectroscopy is a laser-based technique that induces
photon-molecule interactions. Combined with a confocal micro-
scope, sample structures can be targeted to acquire biochemical
information. In Raman microspectroscopy, a sample is excited with
a laser source to induce molecular vibrations. The spectrometer
with a charge coupled device (CCD) camera converts the back-
scattered light, so-called incoherent Raman scattering, to a single
spectrum of the targeted spot. The resulting spectra are comparable
to a biochemical fingerprint. Every peak is assigned to a molecular
vibration and allows for the characterization and analysis of the
sample. Raman spectroscopy is well established in material science
and pharmaceuticals [21–23] and is gaining broader recognition in
the biological and biomedical field [24,25]. Raman spectroscopy is
used in cancer diagnostics [26–28] as well as skin and cardiovascu-
lar research [29,30]. Raman spectroscopy has been applied to detect
lipids in atherosclerosis [29], image SMCs on scaffolds [31] and to
test vascular SMC response in fresh arteries [32]. A recent study
by Molony et al. applied vibrational spectroscopy to distinguish
de-differentiated SMCs from undifferentiated stem cells and their
progenitors [33]. These studies performed analyses at the cellular
level, but no subcellular SMC structures were analyzed.
The objective of this study was to identify and characterize
SMCs applied in tissue engineering on a molecular level. We
assessed the sensitivity and selectivity of Raman microspec-
troscopy as a quality control tool to detect differences between cell
phenotype and populations. Furthermore, we monitored extracel-
lular matrix (ECM) remodeling in tissue-engineered rings com-
prised of human SMCs, similar to rat aortic SMC rings previously
described [34], and compared it to native human tissue.
2. Materials & methods
2.1. Human cell culture
Primary human SMCs isolated from non-vascular [trachea
(HTSMC), uterus (HUtSMC)] and vascular [coronary artery
(HCASMC), pulmonary artery (HPASMC) and aorta (HAoSMC)] tis-
sues were purchased (PromoCell, Heidelberg, Germany). Cells were
thawed and seeded in culture flasks at a density of 6500 cells per
cm2 in SMC Growth Medium 2 (PromoCell), supplemented with
1% Penicillin/Streptomycin (Thermo Fisher Scientific, Waltham,
MA, USA) and SMC supplement mix (PromoCell). Cells were cul-
tured 48–72 h up to a confluency of 80%, detached with EDTA-
Trypsin 0.05% (Thermo Fisher Scientific), and seeded up to passage
20 for further experiments.
2.2. Tissue-engineered rings
Engineered vascular tissue rings derived from hCASMCs and
hAoSMCs (LifeLine Cell Technology LLC, Frederick, MD, USA) were
cultured for 14 days, as described previously [35]. Briefly, hSMCs
were seeded into ring-shaped, non-adhesive agarose wells
(400,000 cells/ring) to form 2 mm diameter rings [36]. The rings
were seeded and cultured in growth medium (GM, LifeLine Cell
Technology LLC) for 24 h, then cultured in differentiation medium
(DMEM, 1% FBS, 1% ITS, 1% Penicillin/Streptomycin [35]), quies-
cence medium (QM) or GM supplemented with 10 ng/ml transfor-
mation growth factor b1 (TGF-b) for 14 days with medium
exchanged daily. Rings were fixed with 4% formalin, paraffin-
embedded and sectioned for Raman measurements and routine
histochemistry (hematoxylin and eosin (H&E), fast green/picrosir-
ius red), as previously described [35].
2.3. Human tissues
Native formalin-fixed and paraffin-embedded human tissues
from pulmonary artery, aorta, trachea and uterus (purchased from
amsbio LLC, Cambridge, MA, USA) were sectioned and mounted
onto cover glasses for Raman measurements.
2.4. Immunocytochemistry (ICC)
Cells were seeded on 1% gelatin coated glass bottom m-dishes
(ibidi GmbH, Martinsried, Germany) and incubated for 24–48 h.
After fixation with 4% PFA (Affymetrics/Thermo-Fisher Scientific)
for 20 min, cells were washed with PBS (Thermo Fisher Scientific),
treated with Triton X-100 0.05% (Fluka/Sigma-Aldrich, St. Louis,
MO, USA) and blocked with goat block (Vector Laboratories, Burlin-
game, CA, USA). Cells were stained for calponin (CNN1 (1:200)),
smooth muscle myosin heavy chain (MYH11 (1:100)), syndecan
(SYN4 (1:400), collagen I (COL1A1 (1:75) and connexin (CX43
(1:200) (Sigma-Aldrich) and stored at 4 !C over night. Immunoflu-
orescence labeling was performed with IgG goat anti-rabbit Alexa-
Fluor 488 secondary antibody (Thermo Fisher Scientific) for 30 min
at room temperature. Cell nuclei were stained with DAPI (Roche,
Basel, Switzerland). Samples were washed and mounted with Pro-
long Gold Antifade (Thermo Fisher Scientific).
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2.5. Real-Time quantitative polymerase chain reaction (qPCR)
Cells of passage 6 were trypsinized and washed with PBS. The
cell pellet (500.000–1.000.000 cells) was suspended in 350 ml RLT
lysis buffer, homogenized (QIAShredder, Qiagen, Hilden, Germany)
and stored at !80 !C until all cell lysates were collected for further
proceeding to total RNA isolation with the RNeasy micro kit (Qia-
gen). Isolated RNA was quantified and qualified using a NanoDrop
spectrometer (Thermo Fisher Scientific) and the Experion" auto-
mated electrophoresis system (Bio-Rad, Hercules, CA, USA). First
strand cDNA was generated in a thermal block cycler (C1000;
Bio-Rad) using reversed transcriptase, a mixture of anchored dT
and random hexamer primer (Qiagen) and 1 mg of total RNA.
Real-time PCR for contractile and synthetic phenotype SMC genes
was performed with the QuantiFast SYBR Green Kit (Qiagen) in
the thermal block cycler combined with a real time system
(CFX96, BioRad). CNN1 (QT00067718), caldesmon (CALD1
(QT00997899)), a-smooth muscle actin (ACTA2 (QT00088102)),
MYH11 (QT00069391) and COL1A1 (QT00037793) and COL3A1
(QT00058233) served as primer and GAPDH (QT01192646) was
used as housekeeping gene (all Qiagen). All data were normalized
to hAoSMC gene expression levels for comparison of gene expres-
sion within the different types of SMC origin. Experiments were
conducted at least as triplicates.
2.6. Raman microspectroscopy and single spectra acquisition
Raman measurements of single cells were obtained with a
custom-build confocal Raman microspectroscope, combining a
confocal microscope with a near-infrared laser source (783 nm) as
previously described [37]. Human tissues and tissue-engineered
rings were cut (10 mm thickness). Sections were collected on
gelatin-coated coverslips as previously described [38]. The tissues
were deparaffinized and kept humid with PBS during the entire
measurement procedure to prevent sample dehydration and burn-
ing. The coverslip was placed on the microscope stage on a 60x
water immersion objective (N.A. 1.2, Olympus, Shinjuku, Japan).
The samples were targeted on the wavy structures of collagen bun-
dles [37] and the laser power was set to 85 mW. Raman measure-
ments were initiated with the Andor iDus spectra acquisition
software (Andor Technology Ltd, Belfast, UK). Spectra were mea-
sured in the Raman fingerprint region from 0 to 2000 cm!1. Each
spectrumwas averaged by the acquisition of 10 spectra. Acquisition
time was 10 s per spectrum, resulting in a total acquisition time of
100 s per spot. 30 spots within each tissue were randomly selected
and measured. Cells were detached with Trypsin – EDTA 0.05% and
washed with PBS by centrifugation (3 min, 1000 rpm). The cell pel-
let was suspended in PBS at a concentration of 1 " 105 cells/ml and
250 ml of the suspension was transferred to a glass bottom dish. The
dish was placed on the microscope stage and cells were targeted in
the middle of the cell. Microscope and acquisition settings were the
same as for the SMC tissues. 30 cells of each passage and origin type
weremeasured. Background spectrawere collected of the glass bot-
tom dish with only PBS (Fig. 1). In addition, lyophilized aggrecan
from bovine articular cartilage (Merck, Darmstadt, Germany) was
used to acquire a proteoglycan reference spectrum at an acquisition
time of 1s and a laser power of 60 mW.
2.7. Raman mapping and imaging
Raman imaging was performed with a customized Raman sys-
tem (WiTec alpha 300 R, Ulm, Germany) equipped with a green
laser (532 nm) and a 63" Apochromat water dipping objective
(N.A. 1.0; Carl Zeiss GmbH). The device is equipped with a CCD
Fig. 1. Principle of Raman microspectroscopy. Isolated human SMC tissues and cells were measured (fixed or in situ). A laser source providing a green (532 nm) or near-
infrared (735 nm) laser passes an optical isolator over a deflection mirror. The laser is led into a beam expander and a downstream polarizer. Afterwards it is directed through
a notch filter and a beam splitter into the objective lens of the microscope and focuses on the sample. Due to molecular interaction, the light is scattered, collected by the lens,
and only the light with a wavelength shift (Raman shift) passes the notch filter and is directed into the spectrometer. In the spectrometer, the light is led through a pinhole
aperture and the different wavelength shifts are separated over a diffraction grating and detected by a change-coupled device camera. The acquisition of a single spectrum or
a spectral map of a defined area and resolution is possible. green: incident laser source; pink: spontaneous Raman scattering; yellow: bright-field setting of the microscope.
(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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camera. A spectrograph with a grating of 600 g/mmwas chosen for
spectral detection. Laser power was set to 39 mW. Samples were
treated the same as for single spectrum acquisition. Images of
SMC rings were acquired at a resolution of 1 mm/pixel and 0.5 s
acquisition time per spectrum. This implied that every mm2 was
described by a single spectrum (Fig. 1).
2.8. Spectral analysis
Single spectral data were pretreated with the spectra process-
ing software OPUS (Bruker, Ettlingen, Germany). Background spec-
tra were subtracted from the sample spectra and the baseline was
corrected. Principal component analysis (PCA) was applied to
define and analyze spectral differences within every spectral data-
set, as described before for the discrimination of different cells
[38,39]. The multivariate data analysis (MVA) software ‘The
Unscrambler X’ (CAMO Software AS, Oslo, Norway) was used. A
PCA identifies spectral differences and similarities on a vector
based algorithm [40–42]. Every vector describes a principal com-
ponent (PC). PC1 is the vector explaining the main variance in
spectral information; however, it often describes differences in
baseline or background. PC2 describes the second most influencing
information and so on. The variance explained by each PC is indi-
cated as percentage number. For every PCA performed in this
study, 7 PCs were calculated based on a nonlinear iterative partial
least square (NIPALS) algorithm. For analysis of the data sets, the
scores plots and the loadings plots of the PCAs were examined.
The scores describe every single spectrum, which can then be dis-
played as a spot in a two-dimensional vector plot based on two
selected PCs. A clustering of the data is shown in the scores plot
if the PC demonstrates spectral differences within the groups.
The loadings plot shows the Raman shift values describing the
information of the selected PC. Peaks shown in the loadings plot
allow to identify the molecular assignments relevant for clustering
of the data in the corresponding PC. Spectra with score values in
the positive range of the PC contained molecular information cor-
relating to the peaks in the positive range of the loadings plot.
Spectra with score values in the negative range of the PC con-
tained information related to the peaks in the negative range of
the loadings plot.
Raman images of the SMC rings were analyzed using Project
FIVE 5.0 software (WiTec). True Component Analysis (TCA) allowed
for identification of single components characterizing the sample.
This method defined similar spectra as the same component and
identified all pixels that provided these spectral characteristics in
an intensity distribution image. Average spectra of the components
were extracted to identify the molecular information of each
component.
An overview of all samples, experiments and performed analy-
ses is provided in the Supporting Information (Supplementary
Table 1).
2.9. Second harmonic generation imaging
HAoSMC rings and aortic tissue samples were analyzed using
second harmonic generation (SHG) of collagen fibers. SHG imaging
was performed with a laser scanning microscope (LSM 880; Carl
Zeiss GmbH, Jena, Germany) combined with a pulsing titanium
sapphire laser (MaiTai, Spectra Physics, Santa Clara, CA, USA). Tis-
sue sections of 10 mm were collected on gelatin-coated glass cover
slips. Paraffin was removed in different washing steps with Xylol.
Images were acquired with a 20x objective (N.A. 0.8, Carl Zeiss
GmbH). The laser power was set to 4%. The SHG signal of collagen
fibers was detected at 800 nm excitation wavelength and a detec-
tor range of 385–410 nm.
2.10. Statistical analysis
Statistical analyses were performed with Prism 6 (GraphPad, La
Jolla, CA, USA). Data are represented as mean ± standard deviation.
Differences were assessed with an analysis of variance (ANOVA). P
values of 0.05 or less were considered statistically significant.
3. Results
3.1. Raman microspectroscopy allows to distinguish hSMCs of different
origins on a single cell-level
Single spectrum acquisition of passage 6 SMCs of different tis-
sue origins in suspension was performed. Representative Raman
spectra of each SMC subtype are shown in Supplementary Fig. 1
(S1). PCA analysis of the data showed that all groups of cells could
be distinguished according to their biological Raman fingerprint
(Fig. 2). PC2/PC3 scores plot showed clustering between all groups.
A clear separation between non-vascular and vascular cells was
observed. However, a clustering within the groups was also pre-
sent (Fig. 2A). Loadings of PC2 and PC3 (Fig. 2C, D) explained spec-
tral differences within the cell types. Peaks in the loadings plot
correlated to molecular information of the samples. PC2 explained
nucleus related differences, described by peaks assigned to DNA
(720 cm!1), DNA bases (e.g. Uracil at 778 cm!1) and DNA backbone
(1090 cm!1). PC3, separating non-vascular and vascular SMCs, cor-
related to cellular components such as membrane related proteins
(775 cm!1), proteins (1250 and 1650 cm!1) and lipids (1125 and
1339 cm!1). Characteristic peaks of all analyses performed in this
study and their molecular assignment are shown in Table 1.
In contrast to the Raman results, routine techniques for gene and
protein expression assessment in cells were not precise enough to
distinguish between the five hSMC groups and to assign the hSMCs
to a certain type of tissue. Real time qPCR for contractile (ACTA2,
CNN1, CALD and MYH11) and synthetic (COL1A1 and COL3A1) SMC
phenotype markers showed differences in gene expression levels
(Fig. 3A–F). However, those results did not enable a clear and fast
differentiation and separation of HSMCs from the different tissues.
Compared to the gene expression in HAoSMCs, that was used as
internal standard, significantly increased levels were only detected
for ACTA2 in HCASMCs (Fig. 3A), for CNN1 in the non-vascular SMCs
(Fig. 3B) and for CALD1 in HCASMCs and HUtSMCs (Fig. 3C).MYH11
expression levels did not significantly differ from each other
(Fig. 3D). Collagen expression levels of both COL1A1 and COL3A1
were modest and did not differ in between the different types of
origin. Solely HTSMCs showed a significant increase in COL3A1
when compared to the other HSMCs (Fig. 3E, F). Detailed statistics
andmultiple comparison of the gene expression levels are provided
in the supporting information (Supplementary Table 2).
Immunofluorescence staining for contractile SMC markers CNN1
and MYH11 was positive for all SMC types of origin. However, ICC
did not allow for a quantitative assessment of the protein expres-
sion levels or a discrimination of the distinct SMCs (Fig. 3G).
3.2. Non-invasive monitoring of phenotypic switching in hSMCs
SMCs of a non-vascular (uterus) and vascular (coronary artery)
origin were cultured for 20 passages and Raman spectroscopic
measurements were taken of 30 cells at every other passage. Com-
parison of similarly composed samples often results in not more
than small spectral changes, peak shifts or intensity differences.
These differences were minimal in the spectral graphs themselves
(Fig. 4A, B). Therefore, spectral data were analyzed by PCA to define
minor spectral alterations. Both populations indicated a shift in
their spectral information over culture time. A shift in score values
196 J. Marzi et al. / Acta Biomaterialia 89 (2019) 193–205
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was detected in PC3 for HUtSMCs (Fig. 4C) and a shift in PC2 was
shown for HCASMCs (Fig. 4D).
Both SMC types showed a significant difference between early
and later passages. In HUtSMC spectra, a significant shift was
detected after passage 6 and passage 12, whereas a continuous
alteration occurred in HCASMCs. HUtSMCs retained a phenotype
intermediate for 2–3 passages and then significantly altered.
HCASMCs up to passage 10 did not differ in their spectral informa-
tion. A significant shift occurred between passage 10 and 12 and
again between passage 16 and 20. According to the loadings plot,
changes in HUtSMCs were mostly based on intensity changes and
peak shifts at 785, 1099, 1310 and 1657 cm!1. These peaks relate
to cellular structures such as the DNA bases in the nucleus [39
40], amino acids [41] and amide I in proteins and C@C and CH2
bonds in lipids [42,43]. Changes in HCASMCs were mainly linked
to peaks at 1102, 1128, 1263 and 1299 cm!1. Similar cellular struc-
tures as for HUtSMCs were identified by those peaks, however, dif-
ferent molecular bonds were affected. Peaks of the PC2 loadings
plot of HCASMC data referred to amino acids and the C–C backbone
in collagen [42,43], amide III in proteins [44], DNA bases in the
nucleus [40] and the acyl backbone in lipids [39].
In parallel to Raman measurements, standard ICC for proteins
corresponding to synthetic phenotype markers was performed
(Fig. 5). Morphological alterations throughout culture time were
visible in bright field images. Whereas low passage HUtSMCs
clearly showed the spindle-shaped morphology of contractile
SMCs and low passage HCASMCs were less differentiated in their
morphology. HUtSMCs significantly shifted in morphology to a
Table 1
Raman peaks and their molecular assignments identified by PCAs.
Peak [cm!1] Molecular assignment Analysis
623 C–C twisting (proteins) [39] Fig. 6E
720 DNA [74] Fig. 2C
775 Phosphatidylinositol [75] Fig. 2D
778 Uracil [76] Fig. 2C
785 DNA [39] Fig. 4E, Fig. 6A
939 Proline (collagen) [44] Fig. 7B
1008 Proteoglycans [55] Fig. 6E
1090 DNA backbone. Phosphate [43] Fig. 2C, Fig. 6A
1099 DNA bases [40] Fig. 4E
1102 DNA bases [40] Fig. 4F
1125 acyl backbone (lipids) [77] Fig. 2D
1128 C-N stretching (proteins) [44] Fig. 4F
1246 Tyrosine (collagen) [44] Fig. 6E
1250 amide III (proteins) [41] Fig. 2D, Fig. 7B
1263 protein band (collagens) [42,43] Fig. 4F
1294 Cytosine [78] Fig. 2C
1297 CH2 deformation (Collagen backbone) [44] Fig. 7B
1299 CH2 deformation (lipids) [39] Fig. 4F
1310 C-N stretching (amines) [41] Fig. 4E
1339 CH2/CH3 twisting (lipids) [77] Fig. 2D
1373 DNA bases [51] Fig. 6A
1434 CH2 deformation [39] Fig. 2C
1440 CH2 bending [42,75,79] Fig. 4D
1446 CH3/CH2 scissoring [27] Fig. 6E
1454 CH2 scissoring/CH3 bending (collagen) [44] Fig. 6E, Fig. 7B
1650 Proteins amide I [40] Fig. 2D
1654 amide I [44] Fig. 4E
1657 C@O stretching, C@lipids) [42,43] Fig. 4E
1663 amide I [44] Fig. 6E
Fig. 2. Raman spectrum analysis of single human SMCs in suspension. (A) Scores plot of normalized and 2nd derivative Raman spectra shows the clustering of all cells of
different tissue origins. In PC3, a separation of vascular SMCs can be detected in the positive range, and non-vascular SMCs in the negative range. Thirty cells were measured
per group. Ellipses indicate a confidence interval of 95%. (B) Phase-contrast bright-field image of targeted cells. Scale bar equals 20 mm. (C, D) Loadings plots of PC2 and PC3
show the spectral ranges that explain the differences within the samples.
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rhomboid, fibroblast-like shape in high passage (Fig. 5A). HCASMCs
also depicted a synthetic phenotype in higher passages. However,
over passage time they did not alter significantly in their morpho-
logical appearance, compared to their low passage shape (Fig. 5B).
Cells of low (4 & 6) and high (20) passage were stained for the con-
tractile phenotype marker CNN1 and three other markers related
to the synthetic SMC phenotype. CX43, COL1A1 and SYN4 are
mainly expressed in SMCs of the synthetic phenotype [15,45]
and have been reported in relation to phenotypic switching in
coronary artery SMCs [46,47], ECM production [48] and aortic
aneurisms [49,50]. ICC for CNN1 showed a decrease of protein
expression over passaging in HUtSMCs (Fig. 5C). Cells of early pas-
sages stained positive for CNN1, in passage 20 only few cells
expressed the contractile marker protein. In HCASMCs no signifi-
cantly different CNN1 expression patterns between high and low
passage cells were found (Fig. 5D). ICC for synthetic SMC pheno-
type proteins was positive in vascular and non-vascular SMCs in
low and high passage. However, COL1A1 was more expressed in
HCASMCs of higher passage, indicating a switch to the synthetic
SMC phenotype.
3.3. Raman microspectroscopy as quality control tool for tissue
engineering approaches
Raman analyses were applied to compare the tissue structures
of tissue-engineered SMC rings to native tissue. SMC rings were
formed by vascular SMCs and can be assembled to a vascular graft
tube with the option to incorporate microspheres or microbeads to
allow supplementation with drugs or growth factors [6,35]. Raman
spectroscopic measurements were performed to non-invasively
analyze the tissue structures of these SMC rings. First, SMC rings
that were cultured under different conditions were compared.
Raman data were acquired from three different groups of rings
constructed out of passage 7 HCASMCs that were cultured for
14 days. SMC rings were cultured in i) growth medium (GM), ii)
quiescence medium (QM) and iii) GM supplemented with TGF b
(GM + TGFb). Raman imaging and single spectra acquisition were
performed to identify the influence of the culture conditions on
the ECM formation of the SMC rings (Fig. 6). Raman imaging and
TCA identified and localized two ECM components and as well as
cell nuclei (Fig. 6A). Peaks related to DNA (785, 1090, 1373 cm!1)
[43,51] could define the structures, that were detected in one com-
ponent of the TCA. One of the remaining components showed peak
assignments reported before for contractile proteins, particularly
actin, in coronary artery and bladder tissue [52,53]. Contractile
proteins were more expressed in SMC rings cultured in QM when
compared to the other culture conditions. SMC rings cultured in
GM showed less collagen structures as well. Supplementation with
TGFb increased contractile protein expression in SMC rings cul-
tured in GM, as observed in SMCs and other cell types [15,35,54].
The third component identified by TCA showed peak assignments
related to a dissolved and dried aggrecan proteoglycan reference
Fig. 3. Protein and gene expression analysis. Real-time quantitative PCR for maker genes expressed in contractile SMCs [ACTA2 (A), CNN1 (B), CALD1 (C), MYH11 (D)] and
synthetic [COL1A1 (E), COL3A1 (F)]. Relative gene expression levels were normalized to HAoSMC levels. *p < 0.05 compared to HAoSMCs, each n = 3. (G) Immunofluorescence
staining of HSMCs of different tissue origins showing nuclei in blue (DAPI) andMYH11 or CNN1 in green. Scale bar equals 50 mm. (For interpretation of the references to colour
in this figure legend, the reader is referred to the web version of this article.)
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(Fig. 6B) and to peaks reported before in proteoglycans and gly-
cosaminoglycans [55]. The proteoglycan component was distinc-
tively expressed in rings in GM culture, TGFb supplementation
did not induce a significant alteration in the expression pattern.
SMC rings cultured in QM only showed modest proteoglycan
deposition.
A PCA was performed on single point measurements of the rings
for detailed analysis of spectral differences and to search for speci-
fic Raman fingerprints, identifying the SMC rings of QM, GM and
GM + TGF culture conditions. A distinct clustering for each culture
condition was detected (Fig. 6C). While PC3 allowed for a signifi-
cant separation between each group, PC 5 allowed for a separation
Fig. 4. PCA of phenotypic switching in HUtSMCs and HCASMCs. Average spectra of HUtSMCs (A) and HCASMCs (B) in different passages (passages 4–20). Spectral regions
indicate differences explained by the PCA (highlighted in grey) at the corresponding Raman shift wavenumbers. (C) PC3 score values of HUtSMCs show a shift in spectral
information over culture time. (D) Passage-dependent alterations are detected in HCASMCs in PC2. Loadings plots of the relevant PCs explain spectral differences within the
HUtSMC (E) and the HCASMC (F) data. n = 30, *p < 0.05, ***p < 0.001.
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of the rings cultured in QM from the rings cultured in GM (Fig. 6D).
Peaks indicating the major spectral differences within the PCs are
shown in the loadings plot (Fig. 6E). PC3 indicated differences in
the peaks at 623, 1446 and 1667 cm!1 assigned to amino acids
and amides in proteins [39,40]. PC5 explained alterations in colla-
gen, described by peaks at 1246, 1401 and 1450 cm!1 [44]. Proteo-
glycans show a significant peak in the Raman shift region of
1008 cm!1 [55]. PC3 and PC5 both showed this peak in the positive
range of their loadings plots. GM and GM + TGF data were mainly
described by positive PC3 values and GM data as well by positive
PC5 data, indicating higher proteoglycan levels in tissue samples
of those culture conditions. PCA results of ECM protein expression
in the differently cultured rings correlated to the Raman imaging
data.
3.4. Assessment of ECM composition in human smooth muscle tissue
and tissue-engineered SMC constructs
Single Raman spectra acquisition of human smooth muscle tis-
sue sections and PCA were performed to determine spectral infor-
Fig. 5. ICC of HUtSMC (A) and HCASMC (B) of different passages. Bright-field images of adherent cells in culture and fixed SMCs of passage 4, 6 and 20, stained for markers
expressed in contractile SMCs (calponin (CNN1)) and synthetic SMCs [connexin (CX43), collagen I (COL1A1) and syndecan (SYN4)] visualized with AlexaFluor488 (green).
Nuclei were stained with DAPI (blue). Mean gray value intensity (GVI) quantification (C, D) showed a significant decrease of CNN1 in HUtSMCs. Scale bars equal 50 mm; n = 3,
*p < 0.05, **p < 0.005. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 6. Raman imaging and PCA of tissue-engineered SMC rings. (A) Raman images of hCASMC rings cultured in quiescence medium (QM), growth medium (GM) and growth
medium that was supplemented with TFG-b (GM + TGF). TCA identified contractile proteins (green), ECM (pink) and nuclei (blue). (B) Comparison of the ECM component
(pink) with a proteoglycan (aggrecan) reference spectrum (grey) identified overlapping peaks. PCA analysis showed differences in the SMC rings depending on the culture
conditions. (C) PC3 vs PC5 scores plot separates the SMC ring groups. (D) Analysis of the single score values for PC3 and PC5 showed a significant difference between all ring
types in PC3, and a significant difference between the two groups cultured in GM and the rings cultured in QM in PC5. (E) The loadings plot indicates peaks that explain the
separation of spectral information in the corresponding PC. Scale bars equal 20 lm. PC score values ± SD, n = 30, ***p < 0.001. (For interpretation of the references to colour in
this figure legend, the reader is referred to the web version of this article.)
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mation and to evaluate the sensitivity of the Raman spectral finger-
print to separate different tissue types. All tissues showed distinct
clustering in the PC2/PC3 scores plot (Fig. 7A). Differences could be
found in PC2 and PC3 score values. The non-vascular tissues clus-
tered in the positive range of PC2, whereas the vascular tissues
clustered in the negative PC2 range. Loadings plot indicating the
main spectral differences within the corresponding PC were used
to analyze the molecular differences between the groups. Loadings
for PC2 and PC3 (Fig. 7B) described matrix related peaks. The peak
at 939 cm!1 was assigned to proline in collagen [44], 1250 cm!1
corresponds to amide III [41] and peaks at 1297 and 1453 cm!1
correlated to the collagen backbone [44]. The PCA identified differ-
ences in the overall matrix structure composition and collagen
content between vascular and non-vascular tissues in PC2. Smaller
differences within the vascular and non-vascular group were
explained by PC3. Each tissue had a characteristic biological Raman
fingerprint, which allowed for separation of all tissues.
Furthermore, to evaluate the influence of the selection of a cell
type for tissue engineering approaches, Raman data were acquired
from an engineered SMC tissue ring sample (Fig. 8A, C, E) con-
structed out of self-assembled HAoSMCs, and compared to native
human aortic tissue (Fig. 8B, D). SHG imaging identified collagen
fibers in both, native and tissue-engineered tissues (Fig. 8D, E).
Analysis of the SHG signals demonstrated a higher collagen content
in the aortic tissue (Fig. 8F). A PCA comparing HAoSMC data to
human aortic tissue data (Fig. 8G) identified a clear similarity of
the structural composition between native and the tissue-
engineered vascular tissues. PC2/PC3 scores plot showed no clus-
tering, although the loadings plots (Fig. 8H) explained matrix
related differences similar to the loadings plots found for the PCA
of aortic, uterine, trachea and pulmonary artery tissues. Spectral
differences within the tissues had a bigger influence on the PCA
than differences between the two samples. Although quantitative
differences in collagen content were detected, single spectrum
acquisition showed that the ring construct out of HAoSMCs pro-
vided ECM structures comparable to the native aortic tissue
composition.
4. Discussion
This study showed a marker-independent approach for the non-
destructive analysis of SMCs and its promising application in tissue
engineering. Raman microspectroscopy allowed for a fast and
marker-independent biochemical characterization and identifica-
tion based on the endogenous spectral fingerprint of cells and tis-
sues. Furthermore, Raman imaging performed on tissue-
engineered SMC constructs enabled non-destructive imaging and
monitoring of ECM remodeling under different culture conditions.
Combined with MVA this technique provided a strong tool for fast
identification and discrimination of SMCs as it has been shown for
the analysis of bone cell phenotypes, cell death stages and stem
cell differentiation [56–58].
PCA results showed that for both tissues and cells, differences
between non-vascular and vascular origin were larger than differ-
ences within these groups. In tissues, non-vascular and vascular
samples were separated due to spectral information on the overall
ECM content. Separation within these groups was described by
minor differences in the biochemical ECM composition. In cells,
differences between non-vascular and vascular SMCs were corre-
sponding to changes in cellular structures such as proteins and
lipids. Differences in DNA content and composition discriminated
the cells within the non-vascular and vascular group of origin. Dif-
ferences of vascular and non-vascular SMCs have also been
described by Gabbiani et al. [19]. They reported predominance of
vimentin filaments and aSMA in vascular SMCs, whereas mainly
desmin was expressed in non-vascular SMCs. Similar specificity
was described for smoothelin isotypes that have been reported to
be found exclusively in vascular SMCs of the contractile phenotype
(smoothelin B) or in visceral SMCs (smoothelin A) [59]. Although
highly specific marker proteins were used in this study, they only
allow to separate non-vascular and vascular SMCs but are not suit-
able to further differentiate vascular SMCs of different origins.
However, those findings correlated to the Raman results explaining
different cellular protein composition as one characteristic of sep-
aration between non-vascular and vascular cell type.
Moreover, Raman spectroscopy enabled marker-free character-
ization and identification of de-differentiation. HUtSMCs and
HCASMCs appeared to differ in their phenotypic switching.
HUTSMCs demonstrated a first phenotypic alteration after passage
6, whereas a significant change of the cell composition was not
detected before passage 10 for HCASMCs. In addition, it was shown
that HUtSMCs underwent a stepwise phenotypic switching, while
HCASMCs indicated a smooth transition to the synthetic pheno-
type. Routine techniques such as PCR or ICC lack reliable markers
to distinguish SMC phenotypes. Moreover, PCR requires precise
sample preparation steps and is highly sensitive to handling accu-
racy, whereas Raman instrumentation and sample processing is
very robust. Huber and Badylak analyzed phenotypic changes in
SMCs of three different tissue origins [20]. They reported difficul-
ties in clearly defining a contractile or synthetic phenotype with
marker proteins such as CNN1, CALD1 and ACTA2. There exists a
broad number of markers related to SMCs, which are dominantly
expressed in either the synthetic or contractile SMC phenotype
[15]. However, this does not imply that those markers are not com-
pletely missing in the other phenotype and can also be expressed
Fig. 7. PCA of Raman single spectrum acquisition of human SMC tissues. (A) Scores
plot of normalized Raman spectra shows clustering of the different tissues. Aortic
tissues are in the PC2 negative and PC3 positive range. Pulmonary artery tissue
cluster in the PC2 negative and PC3 negative range. Uterus and trachea tissues are
both in the PC2 positive range, whereas uterus spectra cluster in positive PC3 and
trachea in PC3 negative range. Thirty spots per tissue were measured. (B) Loadings
plots of PC2 and PC3 indicate the spectral ranges explaining the differences within
the score values.
202 J. Marzi et al. / Acta Biomaterialia 89 (2019) 193–205
Appendix IV 
  135 
in other cell types such as fibroblast or other cardiovascular cells
[60–62]. Moreover, there exist transition states between the syn-
thetic and contractile phenotype. In contrary, Raman microspec-
troscopy did not focus on one defined marker but provided the
overall biomolecular fingerprint of the cell, containing marker-
free molecular information describing the overall cellular composi-
tion and enabling the detection of cellular changes and the defini-
tion of the time point of switching. According to our results, we
conclude that SMCs applied for tissue engineering should be of
passage 6–7 or below to guarantee the dominance of SMCs of func-
tional, contractile phenotype. A study by Timraz et al. investigated
the behavior of HAoSMCs in culture and reported similar results
[63]. Based on the analysis of cell morphology, IHC on MYH11,
aSMA, COL1 and COL3A1 and marker gene expression they identi-
fied passage 7 as the intermediate state between contractile and
synthetic phenotype.
In tissue engineering, there is a need for non-destructive, non-
invasive real-time methods to characterize cells and to monitor
cell-material interactions. A major obstacle for rapidly evolving tis-
sue engineering approaches is to control and monitor the develop-
ment, degeneration and functionality of the biomaterial [64,65].
We showed that Raman spectroscopy provided the desired fea-
tures for a fast determination of the properties of tissue engineered
constructs. Raman imaging and single spectrum acquisition results
of SMC rings in different culture conditions lead to the conclusion
that GM induced an increased proteoglycan production, while QM
helped to maintain the SMCs contractile phenotype with modest
ECM remodeling and proteoglycan expression, but contractile pro-
tein expression. Proteoglycans seemed to play an important role in
vascular SMC-derived ECM expression. These findings were con-
firmed by the results of previous studies that reported higher
expression of lipoprotein-binding proteoglycans in proliferative
vascular SMCs compared to quiescent SMCs [66] and the relevance
of proteoglycans (hyaluronan and versican) for vascular SMC
migration and proliferation [67]. Extensive aggrecan and versican
accumulation has recently been reported in thoracic aortic aneur-
ysm [68] and Suna et al. described the impact of aggrecan in ECM
remodeling in vasculature and reported aggrecan gene expression
specifically in vascular SMCs, whereas vascular endothelial cells
lacked aggrecan gene expression [69]. Raman imaging marker-
independently demonstrated that TGFb supplementation sup-
ported culture conditions to form a tissue ring that develops intact
ECM and contractile protein structures which are necessary to sus-
tain the physiological demands of a native vessel. Tissue-
engineered rings grown in medium with TGFb supplementation
or incorporated with gelatin beads containing TGFb have already
Fig. 8. Comparison of tissue-engineered SMC rings and native aortic tissue. Tissue-engineered SMC rings (A, C, E) and human aorta (B, D) stained with H&E (B, C), and second
harmonic generation (SHG) microscopy to visualize collagen fibers (D, E). Scale bars equal 100 mm. (F) Collagen structures showed higher SHG signal intensities in native
aortic tissue when compared with HAoSMC rings **p < 0.01; n = 5 (G) PCA of normalized hAoSMC ring and native aortic tissue data. PC2/PC3 scores plot, based on principal
components describing tissue ECM structures (H), do not show a separation between tissue-engineered and native data sets.
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been shown to comply with the biomechanical properties of native
tissue [35]. Moreover, the tissue-engineered HAoSMC ring sample
showed molecular information similar to the Raman fingerprint
of the native aorta and differed from other smooth muscle tissues.
The role of the selected SMC type for tissue engineering approaches
has been previously investigated [20,70]. It was discussed that any
SMC type could be applied as long as the regulation of the pheno-
type is controlled, regardless of the smooth muscle organ that
should be reconstructed in vitro. However, our results showed that
except for contractile and synthetic phenotype characteristics,
there are other cellular properties discriminating SMCs of different
tissue origins. There exist significant differences especially
between vascular and non-vascular SMCs. Raman spectroscopy
may help in the assessment and monitoring of variable factors in
tissue engineering such as maturation, dedifferentiation, degrada-
tion and assembly of cells or biomaterials. An increasingly impor-
tant approach is the derivation of SMCs from stem cells and their
application for tissue engineering [71–73]. Further work will focus
on the analysis of stem cell derived tissue engineering approaches
in comparison to native vascular tissues.
5. Conclusion
Raman microspectroscopy and Raman imaging combined with
MVA allowed in this study the non-destructive, marker-
independent identification and characterization of SMCs, smooth
muscle tissues and tissue-engineered SMC constructs. The spectral
information was specific enough to distinguish for the first time
the phenotypic switching in SMCs in real-time, and monitor the
impact of culture conditions on ECM remodeling in the tissue-
engineered SMC constructs. Raman spectroscopy, especially in
combination with machine learning and artificial intelligence tools,
has not only the potential to be employed for the assessment of
cellular properties and the characterization of disease-related
modifications in cells and tissues, but also for the non-
destructive and marker-free assessment of cellular quality and
phenotype stability when dealing with cell manufacturing. It can
further be very useful for the in situ analysis of biomaterials,
cell-(bio)material interactions and to monitor molecular and bio-
chemical changes in tissue-engineered products.
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Appendix V: Raman peaks and their assignments – tissues 
Peak 
[cm-1] 
molecular assignment 
elastin 
(component 1) 
collagens 
(component 2) 
cells/DNA 
(component 3) 
red blood cells 
(component 4) 
    
529 Des/ Isodes277    
669    porphyrin defor-
mation278, 279 
729  tryptophane280   
751    porphyrin ring 
breathing278, 279 
756   A281  
782  C-N stretching277, 282   
825  C-N stretching277   
966 Des/ Isodes277    
999    C-C278, 279 
1101   DNA bases281  
1107 Des/ Isodes277    
1122    porphyrin half 
ring 278, 279 
1128 C-N stretching277  phosphodiester283  
1165 Tyr282    
1179 Tyr*277 G, C283  
1207   NH2 G, C283  
1212 Tyr277    
1218    C-N stretching 284 
1233 amide III285, 286    
1246  Tyr277   
1245  amide III277 A, G281  
1263 protein band287, 288    
1266   G280  
1311 CH2/CH3 twisting, 
bending282 
   
1317   CH2 defor-
mation281 
 
1340  amide III277   
1343 CH2 /CH3 wag-
ging277 
   
1347   deoxyribose283  
1369  amide III (α-helix)282, 
289 
  
1397 CH2 defor-
mation282 
   
1400   C283  
1439  CH2 /CH3 twisting277   
1444    C-C278, 279 
1454 CH2 scissoring /CH3 bending*277  C-C stretching284  
1508  CH3 bending288    
1580  CH2 scissoring /CH3 
bending277 
  
1593    C=N, C=C in 
quinoid ring 284 
1611 Tyr277    
1654 amide I277    
1663  amide I277 DNA290  
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Appendix VI: Raman peaks and their assignments – cells 
 
Peak 
[cm-1] 
molecular assignment 
phospholipids 
(component 1) 
lipids 
(component 2) 
proteins 
(component 3) 
cells/DNA 
(component 4) 
    
715 C-N (phospholipid 
head)280, 281, 291 
CN-(CH3)3281   
720    DNA292 
760   tryptophan281  
786    DNA280 
824   Tyr289  
831    T293 
869   proline280  
875 N+(CH3)3 (choline)291    
878  C-C-N+ stretching 281   
890   protein assign-
ment287, 288 
 
968  lipid assignment288   
1032 CH3/CH2 bending*289   
1057 lipids*288   
1080 phospholipids291    
1090    phosphate288 
1123 C-C stretching*280 C-N, C-C 
stretch289 
 
1177    G, C283 
1248   amide III284  
1251    NH2 G, C283 
1299  CH2 deformation 280   
1302 CH2 twisting289    
1308   C-N stretching 
(amines)284 
 
1335   CH3/CH2 twist-
ing, wagging289 
 
1340    A, G281 
1372    DNA bases293 
1440  CH2 bending287, 291, 294   
1443   CH2 defor-
mation280 
 
1445 CH3/CH2 scissor-
ing289 
   
1577    NADH295, G283 
1656 C=C294    
1657  C=O stretching, 
C=C287, 288 
  
1660   amide I281  
1663    DNA290 
A: adenine, G: guanine T: thymine C: cytosine, Des/Isodes: desomsine/isodesmosine, Tyr: ty-
rosine  
 
*peaks are present in two components 
 
 
